aspirin has been researched along with Prostatic Neoplasms in 162 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Prostatic Neoplasms: Tumors or cancer of the PROSTATE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aspirin and statin use may lower the risk of advanced/fatal prostate cancer, possibly by reducing intraprostatic inflammation." | 9.34 | Use of Aspirin and Statins in Relation to Inflammation in Benign Prostate Tissue in the Placebo Arm of the Prostate Cancer Prevention Trial. ( Arnold, KB; Benedetti, I; De Marzo, AM; Drake, CG; Goodman, PJ; Gumuskaya, B; Hurwitz, LM; Isaacs, WB; Kulac, I; Liu, JO; Lucia, MS; Marrone, MT; Nelson, WG; Pan, F; Platz, EA; Tangen, CM; Thompson, IM; Valle, JABD, 2020) |
| "Regular aspirin use may decrease cancer risk by reducing chronic inflammation." | 9.20 | Association between Regular Aspirin Use and Circulating Markers of Inflammation: A Study within the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. ( Chaturvedi, AK; Hildesheim, A; Katki, HA; Kemp, TJ; Lang Kuhs, KA; Loftfield, E; Pinto, LA; Purdue, MP; Safaeian, M; Shiels, MS; Trabert, B; Wentzensen, N, 2015) |
| "To determine whether patients undergoing transrectal ultrasound (TRUS)-guided prostate biopsy with increased sampling numbers are more likely to experience bleeding complications and whether warfarin or low-dose aspirin are independent risk factors." | 7.78 | Should warfarin or aspirin be stopped prior to prostate biopsy? An analysis of bleeding complications related to increasing sample number regimes. ( Abbas, A; Chowdhury, R; Hoy, A; Idriz, S; Rutherford, EE; Smart, JM, 2012) |
| "Aspirin use was not associated with prostate cancer incidence." | 5.51 | Aspirin and Non-Aspirin NSAID Use and Prostate Cancer Incidence, Mortality, and Case Fatality in the Atherosclerosis Risk in Communities Study. ( Barber, JR; Folsom, AR; Han, M; Hurwitz, LM; Jones, MR; Joshu, CE; Platz, EA; Prizment, AE; Vitolins, MZ, 2019) |
| "Aspirin and statin use may lower the risk of advanced/fatal prostate cancer, possibly by reducing intraprostatic inflammation." | 5.34 | Use of Aspirin and Statins in Relation to Inflammation in Benign Prostate Tissue in the Placebo Arm of the Prostate Cancer Prevention Trial. ( Arnold, KB; Benedetti, I; De Marzo, AM; Drake, CG; Goodman, PJ; Gumuskaya, B; Hurwitz, LM; Isaacs, WB; Kulac, I; Liu, JO; Lucia, MS; Marrone, MT; Nelson, WG; Pan, F; Platz, EA; Tangen, CM; Thompson, IM; Valle, JABD, 2020) |
| "Preclinical, epidemiological, and randomised data indicate that aspirin might prevent tumour development and metastasis, leading to reduced cancer mortality, particularly for gastro-oesophageal and colorectal cancer." | 5.30 | Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial. ( Adams, R; Berkman, L; Bridgewater, J; Cafferty, F; Cameron, D; Crossley, A; Din, F; Falk, S; Gilbert, D; Graham, J; Gupta, K; Henson, V; Hubner, R; Iveson, T; Jankowski, J; Joharatnam-Hogan, N; Khabra, K; Kunene, V; Kynaston, H; Langley, R; Patel, K; Pramesh, CS; Ring, A; Rowley, S; Sothi, S; Swinson, D; Thomas, A; Underwood, T; Warner, N; Wilson, R, 2019) |
| "Regular aspirin use may decrease cancer risk by reducing chronic inflammation." | 5.20 | Association between Regular Aspirin Use and Circulating Markers of Inflammation: A Study within the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. ( Chaturvedi, AK; Hildesheim, A; Katki, HA; Kemp, TJ; Lang Kuhs, KA; Loftfield, E; Pinto, LA; Purdue, MP; Safaeian, M; Shiels, MS; Trabert, B; Wentzensen, N, 2015) |
| " We studied prostate cancer occurrence in the Aspirin/Folate Polyp Prevention Study, a placebo-controlled randomized trial of aspirin and folic acid supplementation for the chemoprevention of colorectal adenomas conducted between July 6, 1994, and December 31, 2006." | 5.14 | Folic acid and risk of prostate cancer: results from a randomized clinical trial. ( Baron, JA; Bresalier, RS; Burke, CA; Figueiredo, JC; Grau, MV; Haile, RW; McKeown-Eyssen, GE; Sandler, RS; Summers, RW, 2009) |
| "Taking aspirin does not increase the risk of hematuria and hematospermia after TRUS-PB." | 5.12 | Safety of transrectal ultrasound-guided prostate biopsy in patients receiving aspirin: An update meta-analysis including 3373 patients. ( Chen, C; Chen, D; Liu, G; Liu, Y; Luo, Z; Xie, Y, 2021) |
| " Bleeding is the most common complication observed after prostate biopsy, but the use of aspirin or nonsteroidal anti-inflammatory drugs is not an absolute contraindication to prostate biopsy." | 4.89 | Complications of prostate biopsy. ( Anastasiadis, A; Antoniewicz, A; Cordeiro, E; De Reijke, T; Dimitriadis, G; Zapała, L, 2013) |
| "To investigate the association of aspirin use with risk of all-cause, any cancer, gastrointestinal (GI) cancer, and colorectal cancer (CRC) mortality among older adults and to perform an exploratory analysis of the association of aspirin use with mortality stratified by BMI." | 3.91 | Association of Aspirin Use With Mortality Risk Among Older Adult Participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. ( Cao, Y; Chan, AT; Loomans-Kropp, HA; Pinsky, P; Umar, A, 2019) |
| "A growing body of evidence indicates that use of low-dose aspirin (LDA) reduces the risk of certain adenocarcinomas." | 3.83 | Risk of prostate cancer in low-dose aspirin users: A retrospective cohort study. ( Cancian, M; Cricelli, C; Cricelli, I; Lapi, F; Levi, M; Parretti, D; Simonetti, M; Sobrero, A, 2016) |
| "From the Swedish Cancer Register, we identified patients diagnosed with colorectal, lung, prostate and breast cancers between 2006 and 2009 and matched them to the Swedish Prescribed Drug Register to obtain information on low-dose aspirin use prior to diagnosis." | 3.79 | Low-dose aspirin use and cancer characteristics: a population-based cohort study. ( Czene, K; Jonsson, F; Lundholm, C; Pawitan, Y; Smedby, KE; Yin, L, 2013) |
| "To determine whether patients undergoing transrectal ultrasound (TRUS)-guided prostate biopsy with increased sampling numbers are more likely to experience bleeding complications and whether warfarin or low-dose aspirin are independent risk factors." | 3.78 | Should warfarin or aspirin be stopped prior to prostate biopsy? An analysis of bleeding complications related to increasing sample number regimes. ( Abbas, A; Chowdhury, R; Hoy, A; Idriz, S; Rutherford, EE; Smart, JM, 2012) |
| "Aspirin has been suggested to reduce the risk of cancer." | 3.01 | Effect of aspirin on incidence, recurrence, and mortality in prostate cancer patients: integrating evidence from randomized controlled trials and real-world studies. ( Feng, L; Gao, J; Guo, X; Jiang, Y; Liu, H; Lowe, S; Ma, S; Qu, G; Sun, C; Sun, Y; Wu, B; Xia, W; Xie, P; Zhou, Z, 2023) |
| "Patients with chronic obstructive pulmonary disease (COPD) are at a higher risk of many types of cancer." | 2.87 | Chronic obstructive pulmonary disease with short-acting inhaled pharmacotherapy increases the risk of prostate cancer: A two-stage database approach. ( Chen, HC; Huang, SW; Lin, HW; Lin, LF; Liou, TH, 2018) |
| "Aspirin target genes were identified through systematic literature review and a drug target database." | 2.87 | Regular aspirin use and gene expression profiles in prostate cancer patients. ( Downer, MK; Ebot, EM; Gerke, TA; Kantoff, PW; Mucci, LA; Rider, JR; Stopsack, KH, 2018) |
| "Add-Aspirin is a phase III, multi-centre, double-blind, placebo-controlled randomised trial with four parallel cohorts." | 2.82 | ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours. ( Berkman, L; Cafferty, FH; Cameron, D; Coyle, C; Gilbert, D; Gupta, S; Kynaston, H; Langley, RE; MacKenzie, M; Pramesh, CS; Ring, A; Rowley, S; Wilson, RH, 2016) |
| "Non-aspirin NSAID use was associated with an increased risk of mild/moderate ED (HR 1." | 2.82 | Non-steroidal anti-inflammatory drug (NSAID) use is not associated with erectile dysfunction risk: results from the Prostate Cancer Prevention Trial. ( Brant, WO; Darke, A; Hotaling, JM; Myers, JB; Patel, DP; Schenk, JM, 2016) |
| "REDUCE tested dutasteride for prostate cancer risk reduction in men with a PSA of 2." | 2.80 | Aspirin, NSAIDs, and risk of prostate cancer: results from the REDUCE study. ( Andriole, GL; Castro-Santamaria, R; Freedland, SJ; Howard, LE; Moreira, DM; Vidal, AC, 2015) |
| "Data from 140 men with prostate cancer enrolled in a Phase 2 clinical trial of selenium to prevent prostate cancer progression were analyzed to determine association between aspirin, other NSAIDs, or statin use with baseline serum prostate-specific antigen (PSA) levels and PSA velocity (rate of PSA change over time) using repeated measures over an average follow-up time of 3." | 2.75 | Effect of aspirin, other NSAIDs, and statins on PSA and PSA velocity. ( Ahmann, FR; Algotar, AM; Hsu, CH; Nagle, RB; Ranger-Moore, J; Stratton, MS; Stratton, SP; Thompson, PA, 2010) |
| "Aspirin is a commonly used medication with anti-inflammatory and analgesic properties, and it is widely used to reduce the risk of ischaemic heart disease-related events and/or cerebrovascular accidents." | 2.72 | The multiple effects of aspirin in prostate cancer patients. ( Bryant, RJ; Joshi, SN; Murphy, EA; Olaniyi, P, 2021) |
| "Beta-carotene's effect on cancer over nearly 13 years was examined overall and within subgroups defined by baseline characteristics using proportional-hazards models." | 2.69 | Effects of beta-carotene supplementation on cancer incidence by baseline characteristics in the Physicians' Health Study (United States). ( Buring, JE; Cook, NR; Hennekens, CH; Le, IM; Manson, JE, 2000) |
| "Preventing prostate cancer via dietary supplements should encourage a "first do no harm" or less-is-more approach until future evidence can reverse the concerning trend that more supplementation has resulted in either no impact or an increased risk of prostate cancer." | 2.66 | Preventing Lethal Prostate Cancer with Diet, Supplements, and Rx: Heart Healthy Continues to Be Prostate Healthy and "First Do No Harm" Part III. ( Moyad, MA, 2020) |
| " At the same time, the dosage and duration of aspirin use had no statistical influence on the risk of PCSM in high/low risk PC." | 2.61 | Could aspirin be a lifesaver for prostate cancer patients in prostate cancer-specific mortality?: an update systematic review and meta-analysis. ( Li, T; Liu, R; Xia, S; Zhou, J, 2019) |
| "Preventing prostate cancer via dietary supplements should encourage a "first do no harm", or less is more approach until future evidence can reverse the concerning trend that more supplementation has resulted in either no impact or an increased risk of prostate cancer." | 2.58 | Preventing Lethal Prostate Cancer with Diet, Supplements, and Rx: Heart Healthy Continues to Be Prostate Healthy and "First Do No Harm" Part I. ( Moyad, MA, 2018) |
| "Aspirin has cyclooxygenase-2 (COX2)-mediated anti-inflammatory and anti-coagulant properties that may confer a positive effect in preventing and limiting the progression of prostate cancer." | 2.58 | Aspirin in the Management of Patients with Prostate Cancer Undergoing Radiotherapy: Friend or Foe? ( Marignol, L; Mascan, B, 2018) |
| "We sampled incident prostate cancer cases from two large U." | 2.55 | Do Aspirin and Other NSAIDs Confer a Survival Benefit in Men Diagnosed with Prostate Cancer? A Pooled Analysis of NIH-AARP and PLCO Cohorts. ( Abnet, CC; Cook, MB; Daugherty, SE; Freedman, ND; Liao, LM; Pfeiffer, R; Zhou, CK, 2017) |
| "Most prostate cancer patients also have comorbidities that are treated with both prescription and nonprescription medications; furthermore, many use dietary supplements." | 2.55 | Common medications and prostate cancer mortality: a review. ( Greenberg, AJ; Mucci, LA; Stopsack, KH, 2017) |
| "Men receiving radiation for prostate cancer frequently want to know what steps they can take to optimize their chance of cure and reduce their risk of side effects." | 2.49 | How can I help myself? A critical review of modifiable behaviors, medications, and complementary alternative medicine for men receiving radiotherapy for prostate cancer. ( Martin, NE; Tseng, YD, 2013) |
| "Work in animals supports cancer reduction with aspirin, but no long-term randomised clinical trials exist in human beings, and randomisation would be ethically unacceptable because vascular protection would have to be denied to a proportion of the participants." | 2.45 | Aspirin, salicylates, and cancer. ( Duthie, GG; Elwood, PC; Gallagher, AM; Morgan, G; Mur, LA, 2009) |
| " The challenge for researchers and clinicians is to further understand which NSAIDs and what dosage and duration may provide the optimal benefit (if any), and to accurately construe the available current data on these agents for patients inquiring about these compounds." | 2.41 | An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II. ( Moyad, MA, 2001) |
| "Our previous studies have confirmed that aspirin combined with Lipitor inhibited the development of prostate cancer (PCa), but the mechanisms need to be comprehensively expounded." | 1.72 | Identification of target and pathway of aspirin combined with Lipitor treatment in prostate cancer through integrated bioinformatics analysis. ( Chen, M; Li, D; Liu, J; Liu, W; Ma, Y; Sheng, Z; Wang, X; Wu, Y; Xu, X; Zhao, D; Zheng, X, 2022) |
| "Aspirin use has been shown to be associated with reduced risk of aggressive prostate cancer, although the mechanisms are not fully understood." | 1.72 | Aspirin use and prostate tumor angiogenesis. ( Clinton, SK; Fu, BC; Giovannucci, EL; Mucci, LA; Wang, K, 2022) |
| "Aspirin use was assessed with a questionnaire." | 1.72 | Urinary Thromboxane B2 and Lethal Prostate Cancer in African American Men. ( Ambs, S; Baker, F; Cook, MB; Dorsey, TH; Kiely, M; Loffredo, CA; Milne, GL; Minas, TZ; Smith, CJ; Tang, W; Yates, C, 2022) |
| "Metformin ever-use was associated with decreased PC incidence compared with non-diabetics (aHR 0." | 1.62 | Population-wide impacts of aspirin, statins, and metformin use on prostate cancer incidence and mortality. ( Cho, MH; Chun, S; Jeong, SM; Koo, HY; Park, J; Shin, DW, 2021) |
| "Aspirin use was assessed at enrollment." | 1.62 | Aspirin Use and Prostate Cancer among African-American Men in the Southern Community Cohort Study. ( Ambs, S; Blot, WJ; Fowke, JH; Hurwitz, LM; Steinwandel, M; Tang, W, 2021) |
| "We identified 1,927 prostate cancer cases during a median follow-up of 17." | 1.56 | Associations of low-dose aspirin or other NSAID use with prostate cancer risk in the Danish Diet, Cancer and Health Study. ( Borre, M; Brasso, K; Dehlendorff, C; Friis, S; Hallas, J; Larsen, SB; Pottegård, A; Skriver, C; Sørensen, HT; Tjønneland, A, 2020) |
| "Follow-up started 1 year after prostate cancer diagnosis." | 1.51 | Use of Low-Dose Aspirin and Mortality After Prostate Cancer Diagnosis: A Nationwide Cohort Study. ( Borre, M; Brasso, K; Dalton, SO; Dehlendorff, C; Friis, S; Hallas, J; Larsen, SB; Nørgaard, M; Pottegård, A; Skriver, C; Sørensen, HT, 2019) |
| "Aspirin use was not associated with prostate cancer incidence." | 1.51 | Aspirin and Non-Aspirin NSAID Use and Prostate Cancer Incidence, Mortality, and Case Fatality in the Atherosclerosis Risk in Communities Study. ( Barber, JR; Folsom, AR; Han, M; Hurwitz, LM; Jones, MR; Joshu, CE; Platz, EA; Prizment, AE; Vitolins, MZ, 2019) |
| "We found that it may be advisable for prostate cancer patients to take aspirin to improve their survival for both prostate cancer mortality and other mortality outcomes." | 1.51 | Aspirin Use and Lethal Prostate Cancer in the Health Professionals Follow-up Study. ( Allard, CB; Chan, JM; Downer, MK; Giovannucci, E; Kenfield, SA; Mucci, LA; Preston, MA; Stampfer, MJ; Wilson, KM, 2019) |
| "The effect of chronic use of low-dose aspirin (LDA) on overall cancer is still unclear owing to many controversial results and methodological limitations of studies." | 1.51 | Reduced risk of cancer among low-dose aspirin users: Data from French health care databases. ( Ajrouche, A; Dalichampt, M; De Rycke, Y; Estellat, C; Hulot, JS; Messika Zeitoun, D; Tubach, F, 2019) |
| "The risk of prostate cancer was measured as standardized incidence ratios (SIR) and 95% confidence intervals (CI), assessing duration of use, age and concomitant statins intake, comparing to the general male background population of the same age in Sweden." | 1.48 | Maintenance use of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk. ( Brusselaers, N; Ma, Y, 2018) |
| "The growth and apoptosis in prostate cancer cells were determined by the trypan blue exclusion and propidium iodide staining assays." | 1.46 | Combined effects of atorvastatin and aspirin on growth and apoptosis in human prostate cancer cells. ( Du, Z; Farischon, C; Goodin, S; He, Y; Huang, H; Li, D; Zhang, K; Zheng, X, 2017) |
| "Aspirin treatment significantly resulted in reduction of matrix metalloproteinase-9 (MMP-9) and upregulation of tissue inhibitors of metalloproteinase-1 (TIMP-1) activity, which are the proteolytic enzymes contributing to the degradation of extracellular matrix and basement membrane in cell invasion and metastasis." | 1.46 | Aspirin Inhibits IKK-β-mediated Prostate Cancer Cell Invasion by Targeting Matrix Metalloproteinase-9 and Urokinase-Type Plasminogen Activator. ( Cao, J; Chen, X; Feng, Y; Liu, B; Shi, C; Zhang, N, 2017) |
| "Aspirin previously has been found to be associated with reduced carcinogenesis of prostate cells." | 1.43 | The association between regular use of aspirin and the prevalence of prostate cancer: Results from the National Health Interview Survey. ( Erickson, SR; Hansen, RA; Huang, WT; Wu, CH, 2016) |
| "Objective The etiology of prostate cancer (PCa) is still unclear." | 1.43 | Postscreening follow-up of the Finnish Prostate Cancer Screening Trial on putative prostate cancer risk factors: vitamin and mineral use, male pattern baldness, pubertal development and non-steroidal anti-inflammatory drug use. ( Auvinen, A; Määttänen, L; Murtola, TJ; Sarre, S; Tammela, TL, 2016) |
| "Aspirin use was not associated with T2E negative PCa (adjusted OR 0." | 1.43 | Aspirin and NSAID use in association with molecular subtypes of prostate cancer defined by TMPRSS2:ERG fusion status. ( Chéry, L; Holt, S; Lin, DW; Luedeke, M; Maier, C; Rinckleb, AE; Stanford, JL; Wright, JL, 2016) |
| "Nonaspirin NSAID use was associated with a slightly increased OR for prostate cancer (1." | 1.43 | Low-dose aspirin or other nonsteroidal anti-inflammatory drug use and prostate cancer risk: a nationwide study. ( Borre, M; Brasso, K; Dehlendorff, C; Friis, S; Hallas, J; Larsen, SB; Skriver, C; Sørensen, HT; Tjønneland, A, 2016) |
| "A 72-year-old man, on treatment for prostate cancer, attended the emergency department with his 2nd episode of spontaneous extensive bruising and haematomas." | 1.43 | Aspirin unmasking acquired haemophilia A in a patient with prostate cancer. ( Keane, F; Khan, AZ; Murad, F; Okiro, JO, 2016) |
| "A possible association between prostate cancer and metabolic syndrome has recently been observed." | 1.43 | [Common medications and prostate cancer : what is the association ?] ( Berthold, D; Grilo, N; Jichlinski, P; M'Baya, O; Rakauskas, A; Valerio, M, 2016) |
| "Nowadays prostate cancer is the most common solid tumor in men from industrialized countries and the second leading cause of death." | 1.42 | Simultaneous treatment with statins and aspirin reduces the risk of prostate cancer detection and tumorigenic properties in prostate cancer cell lines. ( Celma, A; Colás, E; de Torres, I; Doll, A; Garcia, M; Montes, M; Morote, J; Olivan, M; Placer, J; Planas, J; Regis, L; Reventós, J; Rigau, M; Sequeiros, T, 2015) |
| "A decreased risk of prostate cancer (PCa) has been suggested in men taking aspirin, statins and metformin, although the evidence has been conflicting." | 1.42 | The risk of prostate cancer for men on aspirin, statin or antidiabetic medications. ( Adolfsson, J; Clements, M; Grönberg, H; Karlsson, R; Nordström, T, 2015) |
| "Aspirin use was not significantly associated with prostate cancer survival." | 1.42 | Use of non-steroidal anti-inflammatory drugs and prostate cancer survival in the Finnish prostate cancer screening trial. ( Auvinen, A; Määttänen, L; Murtola, TJ; Stenman, UH; Taari, K; Tammela, TL; Veitonmäki, T, 2015) |
| "A total of 92 patients with prostate cancer were divided into observation group (n=44) and control group (n=48)." | 1.42 | Preventive Effects of Aspirin on Cardiovascular Complications in Prostate Cancer Cases after Endocrinotherapy. ( Chen, YF; Li, XX; Shan, YH; Wang, D; Zhang, YG, 2015) |
| "Aspirin use was also associated with reduced rates of distant metastases at 5 years (12." | 1.40 | Aspirin improves outcome in high risk prostate cancer patients treated with radiation therapy. ( Choe, KS; Chun, SG; Hannan, R; Jacobs, CD; Kim, DW; Lotan, Y; Pistenmaa, DA; Roehrborn, CG; Xie, XJ; Yan, J, 2014) |
| "Aspirin has been associated to a reduced risk of colorectal, and possibly of other cancers." | 1.40 | Aspirin and prostate cancer prevention. ( Bosetti, C; Gallus, S; La Vecchia, C; Rosato, V, 2014) |
| " There was also no evidence of dose-response association after adjustments." | 1.40 | Low-dose aspirin and survival in men with prostate cancer: a study using the UK Clinical Practice Research Datalink. ( Cardwell, CR; Coleman, HG; Flahavan, EM; Hughes, CM; Murray, LJ; O'Sullivan, JM; Powe, DG, 2014) |
| "Aspirin use has been associated with reduced mortality from cancer including prostate cancer in some studies." | 1.40 | A cohort study investigating aspirin use and survival in men with prostate cancer. ( Barron, TI; Bennett, K; Flahavan, EM; Sharp, L, 2014) |
| "We recently reported reduced prostate cancer (PCa)-specific mortality for β-blocker users among patients receiving androgen-deprivation therapy in a health survey cohort including 655 PCa patients." | 1.40 | Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease. ( Fagerland, MW; Fosså, SD; Grytli, HH; Taskén, KA, 2014) |
| "We examined prostate cancer risk factors in 74 men who were part of families with a BRCA mutation." | 1.40 | Aspirin use is associated with lower prostate cancer risk in male carriers of BRCA mutations. ( Cossack, M; Ghaffary, C; Lynch, H; Snyder, C; Watson, P, 2014) |
| "Aspirin use was reported at enrollment, in 1997, and every 2 years thereafter." | 1.40 | Daily aspirin use and prostate cancer-specific mortality in a large cohort of men with nonmetastatic prostate cancer. ( Campbell, PT; Freedland, SJ; Gapstur, SM; Jacobs, EJ; Newton, CC; Stevens, VL, 2014) |
| "All new prostate cancer cases in Finland during 1995-2002 and matched controls (24,657 case-control pairs) were identified from national registries." | 1.39 | Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level. ( Auvinen, A; Murtola, TJ; Tammela, TL; Veitonmäki, T, 2013) |
| "Aspirin was negatively associated with high PSA velocity in model 1 (odds ratio (95% confidence interval): 0." | 1.38 | Differences in characteristics of men with localised prostate cancer who demonstrate low, intermediate or high prostate-specific antigen velocity. ( Ahmann, FR; Algotar, AM; Hsu, CH; Nagle, RB; Ranger-Moore, J; Stratton, MS; Stratton, SP; Thompson, PA, 2012) |
| " Further study is needed to confirm these findings and to determine the optimal dosing and schedule, as well as the relative benefits and risks, of both therapies in combination with RT." | 1.38 | Aspirin and statin nonuse associated with early biochemical failure after prostate radiation therapy. ( Buyyounouski, MK; Horwitz, EM; Li, T; Zaorsky, NG, 2012) |
| "The risk of prostate cancer-specific mortality (PCSM) was compared between the AC and non-AC groups." | 1.38 | Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy. ( Carroll, PR; Chan, JM; Choe, KS; Cowan, JE; D'Amico, AV; Liauw, SL, 2012) |
| " Most studies were limited by lack of information on dosage and duration of use of the different classes of NSAIDs." | 1.37 | Use of non-steroidal anti-inflammatory drugs and prostate cancer risk: a population-based nested case-control study. ( Aprikian, AG; Beck, P; Franco, EL; Mahmud, SM; Platt, RW; Sharpe, C; Skarsgard, D; Tonita, J; Turner, D, 2011) |
| " Long-term use of aspirin (>5 years: odds ratio = 0." | 1.36 | Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk. ( Feng, Z; FitzGerald, LM; Kwon, EM; Nelson, PS; Ostrander, EA; Peters, U; Salinas, CA; Stanford, JL, 2010) |
| "Results suggest that aspirin may affect prostate cancer detection, suggesting a potential detection bias to address in future studies of nonsteroidal anti-inflammatory drugs and prostate cancer prevention." | 1.35 | Association of nonsteroidal anti-inflammatory drugs, prostate specific antigen and prostate volume. ( Byerly, S; Chang, SS; Concepcion, R; Cookson, MS; Fowke, JH; Motley, SS; Smith, JA, 2009) |
| "One hundred forty-one prostate cancer cases diagnosed between 1980 and May 2004 were confirmed by medical record review." | 1.33 | Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging. ( Carter, HB; Corrada, MM; De Marzo, AM; Landis, PK; Metter, EJ; Pearson, JD; Platz, EA; Rohrmann, S; Watson, DJ, 2005) |
| "The absolute rate of prostate cancer (standardized to the age distribution of study participants using 5-year age categories) was 1013 per 100,000 person-years among men who had never reported NSAID use, and 847 per 100,000 person-years among long duration regular NSAID users." | 1.33 | A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence. ( Calle, EE; Connell, CJ; Henley, SJ; Jacobs, EJ; Mondul, AM; Rodriguez, C; Thun, MJ, 2005) |
| "The role of aspirin in prostate cancer risk was analysed in a multicentric case-control study conducted in Italy between 1991 and 2002, including 1261 incident cases of carcinoma of the prostate and 1131 hospital controls." | 1.33 | Aspirin and the risk of prostate cancer. ( Bosetti, C; Franceschi, S; La Vecchia, C; Montella, M; Negri, E; Talamini, R, 2006) |
| "The number one or two cause of death in prostate cancer patients is also cardiovascular disease." | 1.32 | The use of complementary/preventive medicine to prevent prostate cancer recurrence/progression following definitive therapy. Part II--rapid review of dietary supplements. ( Moyad, MA, 2003) |
| "Aspirin use was associated with a reduced risk of prostate cancer [odds ratio (OR) = 0." | 1.32 | Inverse association between nonsteroidal anti-inflammatory drugs and prostate cancer. ( García Rodríguez, LA; González-Pérez, A, 2004) |
| "A total of 2,574 men developed prostate cancer." | 1.31 | Daily aspirin use and prostate cancer risk in a large, multiracial cohort in the US. ( Habel, LA; Stanford, JL; Zhao, W, 2002) |
| "Ibuprofen was significantly more effective against human prostate cancer cells in vitro than the other tested nonprescription NSAIDs." | 1.31 | Superior effectiveness of ibuprofen compared with other NSAIDs for reducing the survival of human prostate cancer cells. ( Andrews, J; Andrews, P; Djakiew, D; Krygier, S, 2002) |
| " We noted no evidence of a linear dose-response relationship (P for trend = 0." | 1.31 | Aspirin use in relation to risk of prostate cancer. ( Chan, JM; Colditz, GA; Giovannucci, E; Leitzmann, MF; Ma, J; Stampfer, MJ; Willett, WC, 2002) |
| "The study included 639 patients with prostate cancer and 659 cancer-free controls." | 1.31 | Effect of nonsteroidal anti-inflammatory agents and finasteride on prostate cancer risk. ( Bladou, F; Chartier-Kastler, E; Chautard, D; Coloby, P; Desgrandchamps, F; Fontaine, E; Haillot, O; Irani, J; Lechevallier, E; Pariente, JL; Ravery, V; Soulie, M, 2002) |
| "In particular, the potential for prostate cancer chemoprevention using nonsteroidal anti-inflammatory drugs (cyclo-oxygenase inhibitors; NSAIDs) has received little attention." | 1.30 | Non-steroidal anti-inflammatory drugs and prostate cancer progression. ( Jackson, RT; McRae, CU; Norrish, AE, 1998) |
| "Aspirin use was protective for colorectal cancer (odds ratio, 0." | 1.30 | Association between coronary heart disease and cancers of the breast, prostate, and colon. ( Ahsan, H; Chen, L; Hagan, M; Jacobson, JS; Khan, ZR; Neugut, AI; Pablos-Mendez, A; Rahman, MI; Rosenberg, DJ; Shea, S; Wahid, N, 1998) |
| "Lycopene was the only antioxidant found at significantly lower mean levels in cases than in matched controls (P = 0." | 1.30 | Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. ( Gann, PH; Giovannucci, E; Hennekens, CH; Ma, J; Sacks, FM; Stampfer, MJ; Willett, W, 1999) |
| " Drug intervention should be on a regular schedule--avoid prn dosage of pain medications." | 1.27 | Dilemmas in managing prostate carcinoma (Part II): Metastatic disease. ( Ahmann, FR, 1985) |
| "Aspirin treated patients and platelets incubated with aspirin in vitro both showed increased platelet EPM." | 1.26 | Role of surface negative charge in platelet function related to the hyperreactive state in estrogen-treated prostatic carcinoma. ( Isohisa, I; Jung, SM; Kinoshita, K; Tanoue, K; Yamazaki, H, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (4.32) | 18.7374 |
| 1990's | 8 (4.94) | 18.2507 |
| 2000's | 44 (27.16) | 29.6817 |
| 2010's | 89 (54.94) | 24.3611 |
| 2020's | 14 (8.64) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, BC | 1 |
| Wang, K | 1 |
| Mucci, LA | 7 |
| Clinton, SK | 1 |
| Giovannucci, EL | 3 |
| Wang, X | 1 |
| Wu, Y | 1 |
| Liu, J | 1 |
| Xu, X | 1 |
| Sheng, Z | 1 |
| Liu, W | 1 |
| Chen, M | 1 |
| Ma, Y | 2 |
| Zhao, D | 1 |
| Li, D | 2 |
| Zheng, X | 2 |
| Karelia, DN | 1 |
| Kim, S | 1 |
| Plano, D | 1 |
| Sharma, AK | 1 |
| Jiang, C | 1 |
| Lu, J | 1 |
| Ma, S | 1 |
| Xia, W | 1 |
| Wu, B | 1 |
| Sun, C | 1 |
| Jiang, Y | 1 |
| Liu, H | 2 |
| Lowe, S | 1 |
| Zhou, Z | 1 |
| Xie, P | 1 |
| Gao, J | 1 |
| Feng, L | 1 |
| Guo, X | 1 |
| Qu, G | 1 |
| Sun, Y | 1 |
| Chinnapaka, S | 1 |
| Zheng, G | 1 |
| Chen, A | 1 |
| Munirathinam, G | 1 |
| Joharatnam-Hogan, N | 1 |
| Cafferty, F | 1 |
| Hubner, R | 1 |
| Swinson, D | 1 |
| Sothi, S | 1 |
| Gupta, K | 1 |
| Falk, S | 1 |
| Patel, K | 1 |
| Warner, N | 1 |
| Kunene, V | 1 |
| Rowley, S | 2 |
| Khabra, K | 1 |
| Underwood, T | 1 |
| Jankowski, J | 1 |
| Bridgewater, J | 1 |
| Crossley, A | 1 |
| Henson, V | 1 |
| Berkman, L | 2 |
| Gilbert, D | 2 |
| Kynaston, H | 2 |
| Ring, A | 2 |
| Cameron, D | 2 |
| Din, F | 1 |
| Graham, J | 1 |
| Iveson, T | 1 |
| Adams, R | 1 |
| Thomas, A | 1 |
| Wilson, R | 1 |
| Pramesh, CS | 2 |
| Langley, R | 1 |
| Loomans-Kropp, HA | 1 |
| Pinsky, P | 1 |
| Cao, Y | 1 |
| Chan, AT | 1 |
| Umar, A | 1 |
| Zhou, J | 1 |
| Xia, S | 1 |
| Li, T | 3 |
| Liu, R | 1 |
| Skriver, C | 3 |
| Dehlendorff, C | 3 |
| Borre, M | 3 |
| Brasso, K | 3 |
| Larsen, SB | 3 |
| Tjønneland, A | 2 |
| Pottegård, A | 2 |
| Hallas, J | 3 |
| Sørensen, HT | 3 |
| Friis, S | 3 |
| Prause, LW | 1 |
| Manka, L | 1 |
| Millan, C | 1 |
| Lang, E | 1 |
| Wyler, SF | 1 |
| Grobholz, R | 1 |
| Hammerer-Lercher, A | 1 |
| Sulser, T | 1 |
| Recker, F | 1 |
| Kwiatkowski, M | 1 |
| Eberli, D | 1 |
| Moyad, MA | 4 |
| Hurwitz, LM | 3 |
| Kulac, I | 1 |
| Gumuskaya, B | 1 |
| Valle, JABD | 1 |
| Benedetti, I | 1 |
| Pan, F | 1 |
| Liu, JO | 1 |
| Marrone, MT | 1 |
| Arnold, KB | 1 |
| Goodman, PJ | 1 |
| Tangen, CM | 2 |
| Lucia, MS | 1 |
| Thompson, IM | 2 |
| Drake, CG | 1 |
| Isaacs, WB | 1 |
| Nelson, WG | 1 |
| De Marzo, AM | 3 |
| Platz, EA | 5 |
| Kubota, M | 1 |
| Matsuoka, T | 1 |
| Yamasaki, T | 1 |
| Kokubun, H | 1 |
| Hagimoto, H | 1 |
| Murata, S | 1 |
| Makita, N | 1 |
| Suzuki, I | 1 |
| Abe, Y | 1 |
| Tohi, Y | 1 |
| Tsutsumi, N | 1 |
| Inoue, K | 1 |
| Kawakita, M | 1 |
| Tang, W | 2 |
| Fowke, JH | 2 |
| Steinwandel, M | 1 |
| Blot, WJ | 1 |
| Ambs, S | 2 |
| Joshi, SN | 1 |
| Murphy, EA | 1 |
| Olaniyi, P | 1 |
| Bryant, RJ | 1 |
| Kiely, M | 1 |
| Milne, GL | 1 |
| Minas, TZ | 1 |
| Dorsey, TH | 1 |
| Smith, CJ | 1 |
| Baker, F | 1 |
| Loffredo, CA | 1 |
| Yates, C | 1 |
| Cook, MB | 2 |
| Koo, HY | 1 |
| Jeong, SM | 1 |
| Cho, MH | 1 |
| Chun, S | 1 |
| Shin, DW | 1 |
| Park, J | 1 |
| Chen, D | 1 |
| Liu, G | 1 |
| Xie, Y | 1 |
| Chen, C | 1 |
| Luo, Z | 1 |
| Liu, Y | 2 |
| Campos-Outcalt, D | 1 |
| Zhou, CK | 1 |
| Daugherty, SE | 1 |
| Liao, LM | 1 |
| Freedman, ND | 1 |
| Abnet, CC | 1 |
| Pfeiffer, R | 1 |
| Rakauskas, A | 1 |
| Grilo, N | 1 |
| M'Baya, O | 1 |
| Jichlinski, P | 1 |
| Valerio, M | 1 |
| Berthold, D | 1 |
| Kang, M | 1 |
| Ku, JH | 1 |
| Kwak, C | 1 |
| Kim, HH | 1 |
| Jeong, CW | 1 |
| Brusselaers, N | 1 |
| Mascan, B | 1 |
| Marignol, L | 1 |
| Stopsack, KH | 3 |
| Ebot, EM | 1 |
| Downer, MK | 4 |
| Gerke, TA | 1 |
| Rider, JR | 1 |
| Kantoff, PW | 4 |
| Tamhankar, AS | 1 |
| Patil, SR | 1 |
| Ahluwalia, P | 1 |
| Gautam, G | 1 |
| Gonzalez-Feliciano, AG | 1 |
| Peisch, SF | 1 |
| Gage, RA | 1 |
| Finn, S | 1 |
| Lis, RT | 1 |
| Graff, RE | 1 |
| Pettersson, A | 1 |
| Pernar, CH | 1 |
| Loda, M | 1 |
| Ahearn, TU | 1 |
| Lin, HW | 1 |
| Lin, LF | 1 |
| Chen, HC | 1 |
| Liou, TH | 1 |
| Huang, SW | 1 |
| Surnar, B | 2 |
| Kolishetti, N | 2 |
| Basu, U | 2 |
| Ahmad, A | 2 |
| Goka, E | 1 |
| Marples, B | 2 |
| Kolb, D | 1 |
| Lippman, ME | 1 |
| Dhar, S | 2 |
| Pathak, RK | 1 |
| Sarkar, S | 1 |
| Kumar, A | 1 |
| Ansari, S | 1 |
| Wilczek, K | 1 |
| Ivan, ME | 1 |
| Sauer, CM | 1 |
| Myran, DT | 1 |
| Costentin, CE | 1 |
| Zwisler, G | 1 |
| Safder, T | 1 |
| Papatheodorou, S | 1 |
| Joshu, CE | 1 |
| Barber, JR | 1 |
| Prizment, AE | 1 |
| Vitolins, MZ | 1 |
| Jones, MR | 1 |
| Folsom, AR | 1 |
| Han, M | 1 |
| Dalton, SO | 1 |
| Nørgaard, M | 1 |
| Murtola, TJ | 6 |
| Veitonmäki, T | 4 |
| Allard, CB | 2 |
| Preston, MA | 2 |
| Wilson, KM | 1 |
| Kenfield, SA | 3 |
| Chan, JM | 4 |
| Giovannucci, E | 5 |
| Stampfer, MJ | 7 |
| Mormile, R | 1 |
| Fan, LL | 1 |
| Xie, CP | 1 |
| Wu, YM | 1 |
| Gu, XJ | 1 |
| Chen, YH | 1 |
| Wang, YJ | 1 |
| Ajrouche, A | 1 |
| De Rycke, Y | 1 |
| Dalichampt, M | 1 |
| Messika Zeitoun, D | 1 |
| Hulot, JS | 1 |
| Estellat, C | 1 |
| Tubach, F | 1 |
| Choe, KS | 3 |
| Liauw, SL | 2 |
| Kashiwagi, E | 1 |
| Shiota, M | 1 |
| Yokomizo, A | 1 |
| Itsumi, M | 1 |
| Inokuchi, J | 1 |
| Uchiumi, T | 1 |
| Naito, S | 1 |
| Hamstra, DA | 1 |
| Conlon, AS | 1 |
| Daignault, S | 1 |
| Dunn, RL | 1 |
| Sandler, HM | 1 |
| Hembroff, AL | 1 |
| Zietman, AL | 1 |
| Kaplan, I | 1 |
| Ciezki, J | 1 |
| Kuban, DA | 1 |
| Wei, JT | 1 |
| Sanda, MG | 1 |
| Michalski, JM | 1 |
| Tseng, YD | 1 |
| Martin, NE | 1 |
| Anastasiadis, A | 1 |
| Zapała, L | 1 |
| Cordeiro, E | 1 |
| Antoniewicz, A | 1 |
| Dimitriadis, G | 1 |
| De Reijke, T | 1 |
| Cossack, M | 1 |
| Ghaffary, C | 1 |
| Watson, P | 1 |
| Snyder, C | 1 |
| Lynch, H | 1 |
| Jonsson, F | 1 |
| Yin, L | 1 |
| Lundholm, C | 1 |
| Smedby, KE | 1 |
| Czene, K | 1 |
| Pawitan, Y | 1 |
| Leyh-Bannurah, SR | 1 |
| Hansen, J | 1 |
| Isbarn, H | 1 |
| Steuber, T | 1 |
| Tennstedt, P | 1 |
| Michl, U | 1 |
| Schlomm, T | 1 |
| Haese, A | 1 |
| Heinzer, H | 1 |
| Huland, H | 1 |
| Graefen, M | 1 |
| Budäus, L | 1 |
| Cardwell, CR | 1 |
| Flahavan, EM | 2 |
| Hughes, CM | 1 |
| Coleman, HG | 1 |
| O'Sullivan, JM | 1 |
| Powe, DG | 1 |
| Murray, LJ | 1 |
| Bennett, K | 1 |
| Sharp, L | 1 |
| Barron, TI | 1 |
| Bosetti, C | 3 |
| Rosato, V | 1 |
| Gallus, S | 1 |
| La Vecchia, C | 3 |
| Jacobs, CD | 1 |
| Chun, SG | 1 |
| Yan, J | 1 |
| Xie, XJ | 1 |
| Pistenmaa, DA | 1 |
| Hannan, R | 1 |
| Lotan, Y | 1 |
| Roehrborn, CG | 1 |
| Kim, DW | 1 |
| Chen, JQ | 1 |
| Xie, L | 1 |
| Wang, J | 1 |
| He, Y | 2 |
| Gao, Y | 1 |
| Qin, X | 1 |
| Li, S | 1 |
| Huang, TB | 1 |
| Yan, Y | 1 |
| Guo, ZF | 1 |
| Zhang, XL | 1 |
| Geng, J | 1 |
| Yao, XD | 1 |
| Zheng, JH | 1 |
| Sood, A | 1 |
| Trinh, QD | 1 |
| Jacobs, EJ | 3 |
| Newton, CC | 2 |
| Stevens, VL | 2 |
| Campbell, PT | 2 |
| Freedland, SJ | 4 |
| Gapstur, SM | 2 |
| Bhindi, B | 2 |
| Margel, D | 1 |
| Hamilton, RJ | 1 |
| Fernandes, KA | 1 |
| Trottier, G | 1 |
| Hersey, KM | 1 |
| Finelli, A | 1 |
| Trachtenberg, J | 1 |
| Zlotta, A | 1 |
| Kulkarni, GS | 1 |
| Toi, A | 1 |
| Evans, A | 1 |
| van der Kwast, TH | 1 |
| Fleshner, NE | 1 |
| Trock, BJ | 1 |
| Assayag, J | 1 |
| Pollak, MN | 1 |
| Azoulay, L | 1 |
| Schreiber, D | 1 |
| Chen, SC | 1 |
| Rineer, J | 1 |
| Worth, M | 1 |
| Telivala, T | 1 |
| Schwartz, D | 1 |
| Vidal, AC | 2 |
| Howard, LE | 1 |
| Moreira, DM | 1 |
| Castro-Santamaria, R | 1 |
| Andriole, GL | 2 |
| Sinha, G | 1 |
| Barton, MK | 1 |
| Olivan, M | 1 |
| Rigau, M | 1 |
| Colás, E | 1 |
| Garcia, M | 1 |
| Montes, M | 1 |
| Sequeiros, T | 1 |
| Regis, L | 1 |
| Celma, A | 1 |
| Planas, J | 1 |
| Placer, J | 1 |
| Reventós, J | 1 |
| de Torres, I | 1 |
| Doll, A | 1 |
| Morote, J | 1 |
| Lang Kuhs, KA | 1 |
| Hildesheim, A | 1 |
| Trabert, B | 1 |
| Kemp, TJ | 1 |
| Purdue, MP | 1 |
| Wentzensen, N | 1 |
| Katki, HA | 1 |
| Pinto, LA | 1 |
| Loftfield, E | 1 |
| Safaeian, M | 1 |
| Chaturvedi, AK | 1 |
| Shiels, MS | 1 |
| Nordström, T | 1 |
| Clements, M | 1 |
| Karlsson, R | 1 |
| Adolfsson, J | 1 |
| Grönberg, H | 1 |
| Lee, M | 1 |
| Wong, HL | 1 |
| Gibbs, P | 1 |
| Määttänen, L | 2 |
| Taari, K | 2 |
| Stenman, UH | 1 |
| Tammela, TL | 4 |
| Auvinen, A | 4 |
| Li, XX | 1 |
| Zhang, YG | 1 |
| Wang, D | 1 |
| Chen, YF | 1 |
| Shan, YH | 1 |
| Patel, DP | 1 |
| Schenk, JM | 2 |
| Darke, A | 1 |
| Myers, JB | 1 |
| Brant, WO | 1 |
| Hotaling, JM | 1 |
| Dziki, Ł | 1 |
| Kujawski, R | 1 |
| Mik, M | 1 |
| Berut, M | 1 |
| Dziki, A | 1 |
| Trzciński, R | 1 |
| Wright, JL | 1 |
| Chéry, L | 1 |
| Holt, S | 1 |
| Lin, DW | 1 |
| Luedeke, M | 1 |
| Rinckleb, AE | 1 |
| Maier, C | 1 |
| Stanford, JL | 3 |
| Bhatia, N | 1 |
| Santos, M | 1 |
| Jones, LW | 1 |
| Beckman, JA | 1 |
| Penson, DF | 1 |
| Morgans, AK | 1 |
| Moslehi, J | 1 |
| Lapi, F | 1 |
| Levi, M | 1 |
| Simonetti, M | 1 |
| Cancian, M | 1 |
| Parretti, D | 1 |
| Cricelli, I | 1 |
| Sobrero, A | 1 |
| Cricelli, C | 1 |
| Sarre, S | 1 |
| Talala, K | 1 |
| Tammela, T | 1 |
| Huang, WT | 1 |
| Erickson, SR | 1 |
| Hansen, RA | 1 |
| Wu, CH | 1 |
| Greenberg, AJ | 1 |
| Okiro, JO | 1 |
| Khan, AZ | 1 |
| Keane, F | 1 |
| Murad, F | 1 |
| Coyle, C | 1 |
| Cafferty, FH | 1 |
| MacKenzie, M | 1 |
| Gupta, S | 1 |
| Wilson, RH | 1 |
| Langley, RE | 1 |
| Huang, H | 1 |
| Farischon, C | 1 |
| Du, Z | 1 |
| Zhang, K | 1 |
| Goodin, S | 1 |
| Gaziano, JM | 1 |
| Batista, JL | 1 |
| Shi, C | 1 |
| Zhang, N | 1 |
| Feng, Y | 1 |
| Cao, J | 1 |
| Chen, X | 1 |
| Liu, B | 1 |
| Biers, SM | 1 |
| Brewster, SF | 1 |
| Kristal, AR | 2 |
| Lippman, SM | 1 |
| Figueiredo, JC | 1 |
| Grau, MV | 1 |
| Haile, RW | 1 |
| Sandler, RS | 1 |
| Summers, RW | 1 |
| Bresalier, RS | 1 |
| Burke, CA | 1 |
| McKeown-Eyssen, GE | 1 |
| Baron, JA | 1 |
| Motley, SS | 1 |
| Smith, JA | 1 |
| Cookson, MS | 1 |
| Concepcion, R | 1 |
| Chang, SS | 1 |
| Byerly, S | 1 |
| Pennanen, P | 1 |
| Syvälä, H | 1 |
| Bläuer, M | 1 |
| Ylikomi, T | 1 |
| Elwood, PC | 1 |
| Gallagher, AM | 1 |
| Duthie, GG | 1 |
| Mur, LA | 1 |
| Morgan, G | 1 |
| Algotar, AM | 2 |
| Thompson, PA | 2 |
| Ranger-Moore, J | 2 |
| Stratton, MS | 2 |
| Hsu, CH | 2 |
| Ahmann, FR | 3 |
| Nagle, RB | 2 |
| Stratton, SP | 2 |
| Murad, AS | 1 |
| Down, L | 1 |
| Davey Smith, G | 1 |
| Donovan, JL | 1 |
| Athene Lane, J | 1 |
| Hamdy, FC | 1 |
| Neal, DE | 1 |
| Martin, RM | 1 |
| Salinas, CA | 1 |
| Kwon, EM | 1 |
| FitzGerald, LM | 1 |
| Feng, Z | 1 |
| Nelson, PS | 1 |
| Ostrander, EA | 1 |
| Peters, U | 2 |
| Dhillon, PK | 2 |
| Mahmud, SM | 2 |
| Franco, EL | 2 |
| Turner, D | 1 |
| Platt, RW | 1 |
| Beck, P | 1 |
| Skarsgard, D | 1 |
| Tonita, J | 1 |
| Sharpe, C | 1 |
| Aprikian, AG | 2 |
| Gravitz, L | 1 |
| Taylor, K | 1 |
| Filgate, R | 1 |
| Guo, DY | 1 |
| Macneil, F | 1 |
| Zaorsky, NG | 1 |
| Buyyounouski, MK | 1 |
| Horwitz, EM | 1 |
| Shebl, FM | 1 |
| Sakoda, LC | 1 |
| Black, A | 1 |
| Koshiol, J | 1 |
| Grubb, R | 1 |
| Church, TR | 1 |
| Chia, D | 1 |
| Zhou, C | 1 |
| Chu, LW | 1 |
| Huang, WY | 1 |
| Kirsh, VA | 1 |
| Chatterjee, N | 1 |
| Leitzmann, MF | 2 |
| Hayes, RB | 1 |
| Hsing, AW | 1 |
| Calip, GS | 1 |
| Goodman, P | 1 |
| Parsons, JK | 1 |
| Cowan, JE | 1 |
| Carroll, PR | 1 |
| D'Amico, AV | 2 |
| Chowdhury, R | 1 |
| Abbas, A | 1 |
| Idriz, S | 1 |
| Hoy, A | 1 |
| Rutherford, EE | 1 |
| Smart, JM | 1 |
| Grytli, HH | 1 |
| Fagerland, MW | 1 |
| Fosså, SD | 1 |
| Taskén, KA | 1 |
| Habel, LA | 1 |
| Zhao, W | 1 |
| Andrews, J | 1 |
| Djakiew, D | 1 |
| Krygier, S | 1 |
| Andrews, P | 1 |
| Ma, J | 2 |
| Colditz, GA | 1 |
| Willett, WC | 2 |
| Irani, J | 1 |
| Ravery, V | 1 |
| Pariente, JL | 1 |
| Chartier-Kastler, E | 1 |
| Lechevallier, E | 1 |
| Soulie, M | 1 |
| Chautard, D | 1 |
| Coloby, P | 1 |
| Fontaine, E | 1 |
| Bladou, F | 1 |
| Desgrandchamps, F | 1 |
| Haillot, O | 1 |
| Simon, HB | 1 |
| Gleave, M | 1 |
| Evans, C | 1 |
| Kehinde, EO | 1 |
| Eldeen, AS | 1 |
| Ayesha, A | 1 |
| Anim, JT | 1 |
| Memon, A | 1 |
| Al-Sulaiman, SM | 1 |
| Maan, Z | 1 |
| Cutting, CW | 1 |
| Patel, U | 1 |
| Kerry, S | 1 |
| Pietrzak, P | 1 |
| Perry, MJ | 1 |
| Kirby, RS | 1 |
| Petroski, RA | 1 |
| Griewe, GL | 1 |
| Schenkman, NS | 1 |
| Lloyd, FP | 1 |
| Slivova, V | 1 |
| Valachovicova, T | 1 |
| Sliva, D | 1 |
| Mahmud, S | 1 |
| Franco, E | 1 |
| Aprikian, A | 1 |
| Fedoruk, MN | 1 |
| Giménez-Bonafé, P | 1 |
| Guns, ES | 1 |
| Mayer, LD | 1 |
| Nelson, CC | 1 |
| García Rodríguez, LA | 1 |
| González-Pérez, A | 1 |
| Royle, JS | 1 |
| Ross, JA | 1 |
| Ansell, I | 1 |
| Bollina, P | 1 |
| Tulloch, DN | 1 |
| Habib, FK | 1 |
| Rohrmann, S | 1 |
| Pearson, JD | 1 |
| Corrada, MM | 1 |
| Watson, DJ | 1 |
| Landis, PK | 1 |
| Metter, EJ | 1 |
| Carter, HB | 1 |
| Ihezue, CU | 1 |
| Smart, J | 1 |
| Dewbury, KC | 1 |
| Mehta, R | 1 |
| Burgess, L | 1 |
| Hampton, T | 1 |
| Rodriguez, C | 1 |
| Mondul, AM | 1 |
| Connell, CJ | 1 |
| Henley, SJ | 1 |
| Calle, EE | 1 |
| Thun, MJ | 1 |
| Ozdal, OL | 1 |
| Ozden, C | 1 |
| Benli, K | 1 |
| Gökkaya, S | 1 |
| Bulut, S | 1 |
| Memiş, A | 1 |
| Kim, KM | 1 |
| Song, JJ | 1 |
| An, JY | 1 |
| Kwon, YT | 1 |
| Lee, YJ | 2 |
| Talamini, R | 1 |
| Negri, E | 1 |
| Franceschi, S | 1 |
| Montella, M | 1 |
| Menezes, RJ | 1 |
| Swede, H | 1 |
| Niles, R | 1 |
| Moysich, KB | 1 |
| Tanguay, S | 1 |
| Bégin, LR | 1 |
| Masood, J | 1 |
| Hafeez, A | 1 |
| Calleary, J | 1 |
| Barua, JM | 1 |
| Sutcliffe, S | 1 |
| Gaydos, CA | 1 |
| Viscidi, RP | 1 |
| Jenkins, FJ | 1 |
| Zenilman, JM | 1 |
| Jacobson, LP | 1 |
| Yoo, J | 1 |
| Chen, MH | 1 |
| Rosenzweig, I | 1 |
| Manford, M | 1 |
| Jung, SM | 1 |
| Kinoshita, K | 1 |
| Tanoue, K | 1 |
| Isohisa, I | 1 |
| Yamazaki, H | 1 |
| Heinz, A | 1 |
| Meyer, WW | 1 |
| Hallwachs, O | 1 |
| Viljoen, TC | 1 |
| van Aswegen, CH | 1 |
| du Plessis, DJ | 1 |
| Gembitskiĭ, EV | 1 |
| Begunov, AB | 1 |
| Horan, AH | 1 |
| Norrish, AE | 1 |
| Jackson, RT | 1 |
| McRae, CU | 1 |
| Neugut, AI | 1 |
| Rosenberg, DJ | 1 |
| Ahsan, H | 1 |
| Jacobson, JS | 1 |
| Wahid, N | 1 |
| Hagan, M | 1 |
| Rahman, MI | 1 |
| Khan, ZR | 1 |
| Chen, L | 1 |
| Pablos-Mendez, A | 1 |
| Shea, S | 1 |
| Gann, PH | 1 |
| Willett, W | 1 |
| Sacks, FM | 1 |
| Hennekens, CH | 3 |
| Herget, EJ | 1 |
| Saliken, JC | 1 |
| Donnelly, BJ | 1 |
| Gray, RR | 1 |
| Wiseman, D | 1 |
| Brunet, G | 1 |
| Febbo, PG | 1 |
| Casey, D | 1 |
| Batter, S | 1 |
| Rotem, R | 2 |
| Tzivony, Y | 1 |
| Flescher, E | 2 |
| Farrugia, D | 1 |
| Ansell, W | 1 |
| Singh, M | 1 |
| Philp, T | 1 |
| Chinegwundoh, F | 1 |
| Oliver, RT | 1 |
| Cook, NR | 1 |
| Le, IM | 1 |
| Manson, JE | 1 |
| Buring, JE | 1 |
| Barry, MJ | 1 |
| Pollard, M | 1 |
| Chang, CF | 1 |
| Luckert, PH | 1 |
| Eisen, M | 2 |
| Napp, HE | 2 |
| Vock, R | 2 |
| Aro, JL | 1 |
| Haapiainen, RK | 1 |
| Rannikko, SA | 1 |
| Alfthan, OS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Prospective, Nonrandomized, Study Comparing the Use of Aspirin and Intraoperative Blood Loss and Postoperative Complications Following Open Inguinal Hernia Repair.[NCT02084615] | 300 participants (Anticipated) | Interventional | 2014-08-31 | Enrolling by invitation | |||
| Adaptation of an eHealth (Web-application) Platform for Delivery of a Sedentary Behavior Intervention Among Prostate Cancer Patients[NCT03740035] | 4 participants (Actual) | Observational | 2018-08-13 | Terminated (stopped due to Pl left institution) | |||
| To Investigate Post-procedure Hemorrhage and Cardiovascular Events in Taiwanese Patients Who Continue or Discontinue Low-Dose Aspirin Before Transrectal Prostate Biopsy: a Prospective Randomized Trial[NCT02744937] | Phase 4 | 150 participants (Anticipated) | Interventional | 2016-04-30 | Not yet recruiting | ||
| Comparison Study of a Low-Fat Diet Supplemented With Fish Oil and a Standard Western Diet in Individuals With Prostate Cancer[NCT00798876] | 56 participants (Actual) | Interventional | 2001-12-18 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
20 reviews available for aspirin and Prostatic Neoplasms
| Article | Year |
|---|---|
Effect of aspirin on incidence, recurrence, and mortality in prostate cancer patients: integrating evidence from randomized controlled trials and real-world studies.
Topics: Aspirin; Humans; Incidence; Male; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk | 2023 |
Effect of aspirin on incidence, recurrence, and mortality in prostate cancer patients: integrating evidence from randomized controlled trials and real-world studies.
Topics: Aspirin; Humans; Incidence; Male; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk | 2023 |
Could aspirin be a lifesaver for prostate cancer patients in prostate cancer-specific mortality?: an update systematic review and meta-analysis.
Topics: Aspirin; Case-Control Studies; Humans; Male; Mortality; Neoplasm Grading; Prognosis; Prostate-Specif | 2019 |
Could aspirin be a lifesaver for prostate cancer patients in prostate cancer-specific mortality?: an update systematic review and meta-analysis.
Topics: Aspirin; Case-Control Studies; Humans; Male; Mortality; Neoplasm Grading; Prognosis; Prostate-Specif | 2019 |
Preventing Lethal Prostate Cancer with Diet, Supplements, and Rx: Heart Healthy Continues to Be Prostate Healthy and "First Do No Harm" Part III.
Topics: Adult; Aspirin; Cardiovascular Diseases; Child; Diet; Dietary Supplements; Humans; Hydroxymethylglut | 2020 |
Preventing Lethal Prostate Cancer with Diet, Supplements, and Rx: Heart Healthy Continues to Be Prostate Healthy and "First Do No Harm" Part III.
Topics: Adult; Aspirin; Cardiovascular Diseases; Child; Diet; Dietary Supplements; Humans; Hydroxymethylglut | 2020 |
The multiple effects of aspirin in prostate cancer patients.
Topics: Aspirin; Chemoradiotherapy; Chemotherapy, Adjuvant; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; D | 2021 |
The multiple effects of aspirin in prostate cancer patients.
Topics: Aspirin; Chemoradiotherapy; Chemotherapy, Adjuvant; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; D | 2021 |
Safety of transrectal ultrasound-guided prostate biopsy in patients receiving aspirin: An update meta-analysis including 3373 patients.
Topics: Aspirin; Biopsy, Needle; Clinical Trials as Topic; Gastrointestinal Hemorrhage; Hematuria; Hemosperm | 2021 |
Safety of transrectal ultrasound-guided prostate biopsy in patients receiving aspirin: An update meta-analysis including 3373 patients.
Topics: Aspirin; Biopsy, Needle; Clinical Trials as Topic; Gastrointestinal Hemorrhage; Hematuria; Hemosperm | 2021 |
Do Aspirin and Other NSAIDs Confer a Survival Benefit in Men Diagnosed with Prostate Cancer? A Pooled Analysis of NIH-AARP and PLCO Cohorts.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Comorbidity; Diet Surveys; Early Detection o | 2017 |
Do Aspirin and Other NSAIDs Confer a Survival Benefit in Men Diagnosed with Prostate Cancer? A Pooled Analysis of NIH-AARP and PLCO Cohorts.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Comorbidity; Diet Surveys; Early Detection o | 2017 |
Aspirin in the Management of Patients with Prostate Cancer Undergoing Radiotherapy: Friend or Foe?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Hum | 2018 |
Aspirin in the Management of Patients with Prostate Cancer Undergoing Radiotherapy: Friend or Foe?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Hum | 2018 |
Preventing Lethal Prostate Cancer with Diet, Supplements, and Rx: Heart Healthy Continues to Be Prostate Healthy and "First Do No Harm" Part I.
Topics: Aspirin; Cardiovascular Diseases; Diet; Dietary Supplements; Humans; Hydroxymethylglutaryl-CoA Reduc | 2018 |
Preventing Lethal Prostate Cancer with Diet, Supplements, and Rx: Heart Healthy Continues to Be Prostate Healthy and "First Do No Harm" Part I.
Topics: Aspirin; Cardiovascular Diseases; Diet; Dietary Supplements; Humans; Hydroxymethylglutaryl-CoA Reduc | 2018 |
Effect of long term aspirin use on the incidence of prostate cancer: A systematic review and meta-analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Incidence; Male; Prognosis; Prostatic Neop | 2018 |
Effect of long term aspirin use on the incidence of prostate cancer: A systematic review and meta-analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Incidence; Male; Prognosis; Prostatic Neop | 2018 |
Aspirin Exposure and Mortality Risk among Prostate Cancer Patients: A Systematic Review and Meta-Analysis.
Topics: Aspirin; Cohort Studies; Follow-Up Studies; Humans; Longitudinal Studies; Male; Prostate; Prostatic | 2019 |
Aspirin Exposure and Mortality Risk among Prostate Cancer Patients: A Systematic Review and Meta-Analysis.
Topics: Aspirin; Cohort Studies; Follow-Up Studies; Humans; Longitudinal Studies; Male; Prostate; Prostatic | 2019 |
How can I help myself? A critical review of modifiable behaviors, medications, and complementary alternative medicine for men receiving radiotherapy for prostate cancer.
Topics: Adenocarcinoma; Anti-Inflammatory Agents; Aspirin; Complementary Therapies; Exercise; Health Behavio | 2013 |
How can I help myself? A critical review of modifiable behaviors, medications, and complementary alternative medicine for men receiving radiotherapy for prostate cancer.
Topics: Adenocarcinoma; Anti-Inflammatory Agents; Aspirin; Complementary Therapies; Exercise; Health Behavio | 2013 |
Complications of prostate biopsy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bacterial Infections; Biopsy; Ciprofloxacin; Drug | 2013 |
Complications of prostate biopsy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bacterial Infections; Biopsy; Ciprofloxacin; Drug | 2013 |
Open and robot-assisted radical retropubic prostatectomy in men receiving ongoing low-dose aspirin medication: revisiting an old paradigm?
Topics: Aged; Anticoagulants; Aspirin; Blood Transfusion; Coronary Disease; Heparin, Low-Molecular-Weight; H | 2014 |
Open and robot-assisted radical retropubic prostatectomy in men receiving ongoing low-dose aspirin medication: revisiting an old paradigm?
Topics: Aged; Anticoagulants; Aspirin; Blood Transfusion; Coronary Disease; Heparin, Low-Molecular-Weight; H | 2014 |
Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cohort Studies; Humans; Incidence; Male; Odds Rati | 2014 |
Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cohort Studies; Humans; Incidence; Male; Odds Rati | 2014 |
Aspirin use and the risk of prostate cancer: a meta-analysis of 24 epidemiologic studies.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Epidemiologic Studies; Humans; Male; Prostatic Neo | 2014 |
Aspirin use and the risk of prostate cancer: a meta-analysis of 24 epidemiologic studies.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Epidemiologic Studies; Humans; Male; Prostatic Neo | 2014 |
Cardiovascular Effects of Androgen Deprivation Therapy for the Treatment of Prostate Cancer: ABCDE Steps to Reduce Cardiovascular Disease in Patients With Prostate Cancer.
Topics: Aged; Androgen Antagonists; Aspirin; Blood Pressure; Cardiovascular Diseases; Cholesterol; Diabetes | 2016 |
Cardiovascular Effects of Androgen Deprivation Therapy for the Treatment of Prostate Cancer: ABCDE Steps to Reduce Cardiovascular Disease in Patients With Prostate Cancer.
Topics: Aged; Androgen Antagonists; Aspirin; Blood Pressure; Cardiovascular Diseases; Cholesterol; Diabetes | 2016 |
Common medications and prostate cancer mortality: a review.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Dietary Supplements; Humans; Hydroxy | 2017 |
Common medications and prostate cancer mortality: a review.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Dietary Supplements; Humans; Hydroxy | 2017 |
Aspirin, salicylates, and cancer.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Breast Neoplasms; Case-Control | 2009 |
Aspirin, salicylates, and cancer.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Breast Neoplasms; Case-Control | 2009 |
Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Chemoprevention; Epidemiolog | 2004 |
Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Chemoprevention; Epidemiolog | 2004 |
An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colorectal Neoplasms; Cyclooxygenase 2; Cyclooxyge | 2001 |
An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colorectal Neoplasms; Cyclooxygenase 2; Cyclooxyge | 2001 |
19 trials available for aspirin and Prostatic Neoplasms
| Article | Year |
|---|---|
Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial.
Topics: Aged; Antineoplastic Agents; Aspirin; Breast Neoplasms; Colorectal Neoplasms; Combined Modality Ther | 2019 |
Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial.
Topics: Aged; Antineoplastic Agents; Aspirin; Breast Neoplasms; Colorectal Neoplasms; Combined Modality Ther | 2019 |
Use of Aspirin and Statins in Relation to Inflammation in Benign Prostate Tissue in the Placebo Arm of the Prostate Cancer Prevention Trial.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Double-Blind Method; H | 2020 |
Use of Aspirin and Statins in Relation to Inflammation in Benign Prostate Tissue in the Placebo Arm of the Prostate Cancer Prevention Trial.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Double-Blind Method; H | 2020 |
Regular aspirin use and gene expression profiles in prostate cancer patients.
Topics: Aspirin; Follow-Up Studies; Humans; Male; Prostatic Neoplasms; Risk Factors; Transcriptome | 2018 |
Regular aspirin use and gene expression profiles in prostate cancer patients.
Topics: Aspirin; Follow-Up Studies; Humans; Male; Prostatic Neoplasms; Risk Factors; Transcriptome | 2018 |
Chronic obstructive pulmonary disease with short-acting inhaled pharmacotherapy increases the risk of prostate cancer: A two-stage database approach.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Aspirin; Cross-Sectional Studies; Databa | 2018 |
Chronic obstructive pulmonary disease with short-acting inhaled pharmacotherapy increases the risk of prostate cancer: A two-stage database approach.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Aspirin; Cross-Sectional Studies; Databa | 2018 |
Aspirin, NSAIDs, and risk of prostate cancer: results from the REDUCE study.
Topics: 5-alpha Reductase Inhibitors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Double-Blind M | 2015 |
Aspirin, NSAIDs, and risk of prostate cancer: results from the REDUCE study.
Topics: 5-alpha Reductase Inhibitors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Double-Blind M | 2015 |
Association between Regular Aspirin Use and Circulating Markers of Inflammation: A Study within the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biomarkers; Colorectal Neoplasms; Early Dete | 2015 |
Association between Regular Aspirin Use and Circulating Markers of Inflammation: A Study within the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biomarkers; Colorectal Neoplasms; Early Dete | 2015 |
Non-steroidal anti-inflammatory drug (NSAID) use is not associated with erectile dysfunction risk: results from the Prostate Cancer Prevention Trial.
Topics: 5-alpha Reductase Inhibitors; Age Distribution; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspir | 2016 |
Non-steroidal anti-inflammatory drug (NSAID) use is not associated with erectile dysfunction risk: results from the Prostate Cancer Prevention Trial.
Topics: 5-alpha Reductase Inhibitors; Age Distribution; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspir | 2016 |
Non-Steroidal Anti-Inflammatory Drugs and Cancer Death in the Finnish Prostate Cancer Screening Trial.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Finland; Follow-Up Studies; Humans; Incidenc | 2016 |
Non-Steroidal Anti-Inflammatory Drugs and Cancer Death in the Finnish Prostate Cancer Screening Trial.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Finland; Follow-Up Studies; Humans; Incidenc | 2016 |
ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Breast Neoplasms; Chemotherapy, Adjuvant; Colorect | 2016 |
ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Breast Neoplasms; Chemotherapy, Adjuvant; Colorect | 2016 |
Regular Aspirin Use and the Risk of Lethal Prostate Cancer in the Physicians' Health Study.
Topics: Adult; Aged; Aged, 80 and over; Anticarcinogenic Agents; Aspirin; Boston; Disease Progression; Human | 2017 |
Regular Aspirin Use and the Risk of Lethal Prostate Cancer in the Physicians' Health Study.
Topics: Adult; Aged; Aged, 80 and over; Anticarcinogenic Agents; Aspirin; Boston; Disease Progression; Human | 2017 |
Folic acid and risk of prostate cancer: results from a randomized clinical trial.
Topics: Adenoma; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colorectal Neopl | 2009 |
Folic acid and risk of prostate cancer: results from a randomized clinical trial.
Topics: Adenoma; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colorectal Neopl | 2009 |
Effect of aspirin, other NSAIDs, and statins on PSA and PSA velocity.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Body Mass Index; Disease | 2010 |
Effect of aspirin, other NSAIDs, and statins on PSA and PSA velocity.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Body Mass Index; Disease | 2010 |
Associations of aspirin, nonsteroidal anti-inflammatory drug and paracetamol use with PSA-detected prostate cancer: findings from a large, population-based, case-control study (the ProtecT study).
Topics: Acetaminophen; Aged; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cas | 2011 |
Associations of aspirin, nonsteroidal anti-inflammatory drug and paracetamol use with PSA-detected prostate cancer: findings from a large, population-based, case-control study (the ProtecT study).
Topics: Acetaminophen; Aged; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cas | 2011 |
Indications for and use of nonsteroidal antiinflammatory drugs and the risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.
Topics: Acetaminophen; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Aspirin; Cohort Studies; Co | 2012 |
Indications for and use of nonsteroidal antiinflammatory drugs and the risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.
Topics: Acetaminophen; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Aspirin; Cohort Studies; Co | 2012 |
Effect of short-term finasteride therapy on peroperative bleeding in patients who were candidates for transurethral resection of the prostate (TUR-P): a randomized controlled study.
Topics: Age Factors; Aged; Anticoagulants; Aspirin; Finasteride; Hemoglobins; Humans; Male; Middle Aged; Pro | 2005 |
Effect of short-term finasteride therapy on peroperative bleeding in patients who were candidates for transurethral resection of the prostate (TUR-P): a randomized controlled study.
Topics: Age Factors; Aged; Anticoagulants; Aspirin; Finasteride; Hemoglobins; Humans; Male; Middle Aged; Pro | 2005 |
[Clinical value of thrombocyte aggregation inhibitors during massive-dose estrogen therapy].
Topics: Aged; Anticoagulants; Antineoplastic Agents; Aspirin; Clinical Trials as Topic; Diethylstilbestrol; | 1984 |
[Clinical value of thrombocyte aggregation inhibitors during massive-dose estrogen therapy].
Topics: Aged; Anticoagulants; Antineoplastic Agents; Aspirin; Clinical Trials as Topic; Diethylstilbestrol; | 1984 |
The V89L polymorphism in the 5alpha-reductase type 2 gene and risk of prostate cancer.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Anti | 1999 |
The V89L polymorphism in the 5alpha-reductase type 2 gene and risk of prostate cancer.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Anti | 1999 |
Effects of beta-carotene supplementation on cancer incidence by baseline characteristics in the Physicians' Health Study (United States).
Topics: Adult; Aged; Aged, 80 and over; Aspirin; beta Carotene; Body Mass Index; Cardiovascular Diseases; Co | 2000 |
Effects of beta-carotene supplementation on cancer incidence by baseline characteristics in the Physicians' Health Study (United States).
Topics: Adult; Aged; Aged, 80 and over; Aspirin; beta Carotene; Body Mass Index; Cardiovascular Diseases; Co | 2000 |
High dose polyoestradiol phosphate with and without acetosalicylic acid versus orchiectomy in the treatment of prostatic cancer. Finnprostate Group.
Topics: Aged; Aspirin; Cardiovascular Diseases; Estradiol; Estradiol Congeners; Follow-Up Studies; Humans; M | 1989 |
High dose polyoestradiol phosphate with and without acetosalicylic acid versus orchiectomy in the treatment of prostatic cancer. Finnprostate Group.
Topics: Aged; Aspirin; Cardiovascular Diseases; Estradiol; Estradiol Congeners; Follow-Up Studies; Humans; M | 1989 |
123 other studies available for aspirin and Prostatic Neoplasms
| Article | Year |
|---|---|
Aspirin use and prostate tumor angiogenesis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Follow-Up Studies; Humans; Male; Neovascularizatio | 2022 |
Aspirin use and prostate tumor angiogenesis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Follow-Up Studies; Humans; Male; Neovascularizatio | 2022 |
Identification of target and pathway of aspirin combined with Lipitor treatment in prostate cancer through integrated bioinformatics analysis.
Topics: Aspirin; Atorvastatin; Cell Cycle Proteins; Computational Biology; DNA Primase; Gene Expression Regu | 2022 |
Identification of target and pathway of aspirin combined with Lipitor treatment in prostate cancer through integrated bioinformatics analysis.
Topics: Aspirin; Atorvastatin; Cell Cycle Proteins; Computational Biology; DNA Primase; Gene Expression Regu | 2022 |
Seleno-aspirin compound AS-10 promotes histone acetylation ahead of suppressing androgen receptor transcription, G1 arrest, and apoptosis of prostate cancer cells.
Topics: Androgen Antagonists; Apoptosis; Aspirin; Caspases; Histones; Humans; Male; Prostate; Prostatic Neop | 2023 |
Seleno-aspirin compound AS-10 promotes histone acetylation ahead of suppressing androgen receptor transcription, G1 arrest, and apoptosis of prostate cancer cells.
Topics: Androgen Antagonists; Apoptosis; Aspirin; Caspases; Histones; Humans; Male; Prostate; Prostatic Neop | 2023 |
Nitro aspirin (NCX4040) induces apoptosis in PC3 metastatic prostate cancer cells via hydrogen peroxide (H
Topics: Apoptosis; Aspirin; Cell Movement; Cell Proliferation; Humans; Hydrogen Peroxide; Male; Nitro Compou | 2019 |
Nitro aspirin (NCX4040) induces apoptosis in PC3 metastatic prostate cancer cells via hydrogen peroxide (H
Topics: Apoptosis; Aspirin; Cell Movement; Cell Proliferation; Humans; Hydrogen Peroxide; Male; Nitro Compou | 2019 |
Association of Aspirin Use With Mortality Risk Among Older Adult Participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Topics: Aged; Aspirin; Body Mass Index; Clinical Trials as Topic; Cohort Studies; Colorectal Neoplasms; Fema | 2019 |
Association of Aspirin Use With Mortality Risk Among Older Adult Participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Topics: Aged; Aspirin; Body Mass Index; Clinical Trials as Topic; Cohort Studies; Colorectal Neoplasms; Fema | 2019 |
Associations of low-dose aspirin or other NSAID use with prostate cancer risk in the Danish Diet, Cancer and Health Study.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Denmark; Diet; Humans; Male; Middle Aged; Pr | 2020 |
Associations of low-dose aspirin or other NSAID use with prostate cancer risk in the Danish Diet, Cancer and Health Study.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Denmark; Diet; Humans; Male; Middle Aged; Pr | 2020 |
Influence of regular aspirin intake on PSA values, prostate cancer incidence and overall survival in a prospective screening trial (ERSPC Aarau).
Topics: Aged; Aspirin; Early Detection of Cancer; Humans; Incidence; Male; Middle Aged; Prospective Studies; | 2020 |
Influence of regular aspirin intake on PSA values, prostate cancer incidence and overall survival in a prospective screening trial (ERSPC Aarau).
Topics: Aged; Aspirin; Early Detection of Cancer; Humans; Incidence; Male; Middle Aged; Prospective Studies; | 2020 |
Effect of Continued Perioperative Anticoagulant Therapy on Bleeding Outcomes Following Robot-assisted Radical Prostatectomy.
Topics: Aged; Anticoagulants; Antithrombins; Aspirin; Blood Transfusion; Clopidogrel; Continuity of Patient | 2021 |
Effect of Continued Perioperative Anticoagulant Therapy on Bleeding Outcomes Following Robot-assisted Radical Prostatectomy.
Topics: Aged; Anticoagulants; Antithrombins; Aspirin; Blood Transfusion; Clopidogrel; Continuity of Patient | 2021 |
Aspirin Use and Prostate Cancer among African-American Men in the Southern Community Cohort Study.
Topics: Aspirin; Black or African American; Cohort Studies; Humans; Male; Middle Aged; Prostatic Neoplasms; | 2021 |
Aspirin Use and Prostate Cancer among African-American Men in the Southern Community Cohort Study.
Topics: Aspirin; Black or African American; Cohort Studies; Humans; Male; Middle Aged; Prostatic Neoplasms; | 2021 |
Urinary Thromboxane B2 and Lethal Prostate Cancer in African American Men.
Topics: Aspirin; Black or African American; Humans; Male; Prostatic Neoplasms; Thromboxane A2; Thromboxane B | 2022 |
Urinary Thromboxane B2 and Lethal Prostate Cancer in African American Men.
Topics: Aspirin; Black or African American; Humans; Male; Prostatic Neoplasms; Thromboxane A2; Thromboxane B | 2022 |
Population-wide impacts of aspirin, statins, and metformin use on prostate cancer incidence and mortality.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Cohort Studies; Health Surveys; Humans; Hydroxymethylglutar | 2021 |
Population-wide impacts of aspirin, statins, and metformin use on prostate cancer incidence and mortality.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Cohort Studies; Health Surveys; Humans; Hydroxymethylglutar | 2021 |
USPSTF recommendations: A 2017 roundup.
Topics: Advisory Committees; Aspirin; Breast Feeding; Cardiovascular Diseases; Colorectal Neoplasms; Dose-Re | 2017 |
USPSTF recommendations: A 2017 roundup.
Topics: Advisory Committees; Aspirin; Breast Feeding; Cardiovascular Diseases; Colorectal Neoplasms; Dose-Re | 2017 |
[Common medications and prostate cancer : what is the association ?]
Topics: Aspirin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Male; Metaboli | 2016 |
[Common medications and prostate cancer : what is the association ?]
Topics: Aspirin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Male; Metaboli | 2016 |
Effects of Aspirin, Nonsteroidal Anti-inflammatory Drugs, Statin, and COX2 Inhibitor on the Developments of Urological Malignancies: A Population-Based Study with 10-Year Follow-up Data in Korea.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase 2 I | 2018 |
Effects of Aspirin, Nonsteroidal Anti-inflammatory Drugs, Statin, and COX2 Inhibitor on the Developments of Urological Malignancies: A Population-Based Study with 10-Year Follow-up Data in Korea.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase 2 I | 2018 |
Maintenance use of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans | 2018 |
Maintenance use of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans | 2018 |
Does Continuation of Low-Dose Aspirin During Robot-Assisted Radical Prostatectomy Compromise Surgical Outcomes?
Topics: Aged; Aspirin; Blood Loss, Surgical; Blood Transfusion; Drainage; Hemoglobins; Humans; Male; Middle | 2018 |
Does Continuation of Low-Dose Aspirin During Robot-Assisted Radical Prostatectomy Compromise Surgical Outcomes?
Topics: Aged; Aspirin; Blood Loss, Surgical; Blood Transfusion; Drainage; Hemoglobins; Humans; Male; Middle | 2018 |
A Prospective Study of Aspirin Use and Prostate Cancer Risk by
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Follow-Up Studies; Humans; Incidence; | 2018 |
A Prospective Study of Aspirin Use and Prostate Cancer Risk by
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Follow-Up Studies; Humans; Incidence; | 2018 |
Reduction of Cisplatin-Induced Ototoxicity without Compromising Its Antitumor Activity.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Aspirin; Cell Pr | 2018 |
Reduction of Cisplatin-Induced Ototoxicity without Compromising Its Antitumor Activity.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Aspirin; Cell Pr | 2018 |
A designer bow-tie combination therapeutic platform: An approach to resistant cancer treatment by simultaneous delivery of cytotoxic and anti-inflammatory agents and radiation.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Aspirin; Cell Line, Tumor; Cell Survival; | 2018 |
A designer bow-tie combination therapeutic platform: An approach to resistant cancer treatment by simultaneous delivery of cytotoxic and anti-inflammatory agents and radiation.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Aspirin; Cell Line, Tumor; Cell Survival; | 2018 |
Aspirin and Non-Aspirin NSAID Use and Prostate Cancer Incidence, Mortality, and Case Fatality in the Atherosclerosis Risk in Communities Study.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Atherosclerosis; Ethnicity; Follow-Up Studies; Hum | 2019 |
Aspirin and Non-Aspirin NSAID Use and Prostate Cancer Incidence, Mortality, and Case Fatality in the Atherosclerosis Risk in Communities Study.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Atherosclerosis; Ethnicity; Follow-Up Studies; Hum | 2019 |
Use of Low-Dose Aspirin and Mortality After Prostate Cancer Diagnosis: A Nationwide Cohort Study.
Topics: Adenocarcinoma; Adult; Age of Onset; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroida | 2019 |
Use of Low-Dose Aspirin and Mortality After Prostate Cancer Diagnosis: A Nationwide Cohort Study.
Topics: Adenocarcinoma; Adult; Age of Onset; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroida | 2019 |
Aspirin and Prostate Cancer Mortality: The Role of Tumor Grading Misclassification?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cohort Studies; Humans; Male; Neoplasm Grading; Pr | 2019 |
Aspirin and Prostate Cancer Mortality: The Role of Tumor Grading Misclassification?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cohort Studies; Humans; Male; Neoplasm Grading; Pr | 2019 |
Aspirin Use and Lethal Prostate Cancer in the Health Professionals Follow-up Study.
Topics: Adult; Aged; Aspirin; Disease Progression; Follow-Up Studies; Health Personnel; Humans; Male; Middle | 2019 |
Aspirin Use and Lethal Prostate Cancer in the Health Professionals Follow-up Study.
Topics: Adult; Aged; Aspirin; Disease Progression; Follow-Up Studies; Health Personnel; Humans; Male; Middle | 2019 |
Aspirin and Prostate Cancer Incidence and Mortality-Letter.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Atherosclerosis; Humans; Incidence; Male; Prostati | 2019 |
Aspirin and Prostate Cancer Incidence and Mortality-Letter.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Atherosclerosis; Humans; Incidence; Male; Prostati | 2019 |
Reduced risk of cancer among low-dose aspirin users: Data from French health care databases.
Topics: Aged; Aged, 80 and over; Aspirin; Breast Neoplasms; Databases, Factual; Dose-Response Relationship, | 2019 |
Reduced risk of cancer among low-dose aspirin users: Data from French health care databases.
Topics: Aged; Aged, 80 and over; Aspirin; Breast Neoplasms; Databases, Factual; Dose-Response Relationship, | 2019 |
Effects of aspirin on cancer initiation and progression.
Topics: Antineoplastic Agents; Aspirin; Cyclooxygenase 2 Inhibitors; Disease Progression; Humans; Male; Neop | 2013 |
Effects of aspirin on cancer initiation and progression.
Topics: Antineoplastic Agents; Aspirin; Cyclooxygenase 2 Inhibitors; Disease Progression; Humans; Male; Neop | 2013 |
Prostaglandin receptor EP3 mediates growth inhibitory effect of aspirin through androgen receptor and contributes to castration resistance in prostate cancer cells.
Topics: Antineoplastic Agents; Aspirin; Castration; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase Inh | 2013 |
Prostaglandin receptor EP3 mediates growth inhibitory effect of aspirin through androgen receptor and contributes to castration resistance in prostate cancer cells.
Topics: Antineoplastic Agents; Aspirin; Castration; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase Inh | 2013 |
Multi-institutional prospective evaluation of bowel quality of life after prostate external beam radiation therapy identifies patient and treatment factors associated with patient-reported outcomes: the PROSTQA experience.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Con | 2013 |
Multi-institutional prospective evaluation of bowel quality of life after prostate external beam radiation therapy identifies patient and treatment factors associated with patient-reported outcomes: the PROSTQA experience.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Con | 2013 |
Aspirin use is associated with lower prostate cancer risk in male carriers of BRCA mutations.
Topics: Aspirin; Genes, BRCA1; Genes, BRCA2; Genetic Carrier Screening; Humans; Male; Mutation; Prostatic Ne | 2014 |
Aspirin use is associated with lower prostate cancer risk in male carriers of BRCA mutations.
Topics: Aspirin; Genes, BRCA1; Genes, BRCA2; Genetic Carrier Screening; Humans; Male; Mutation; Prostatic Ne | 2014 |
Low-dose aspirin use and cancer characteristics: a population-based cohort study.
Topics: Adenocarcinoma; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Breast Neoplasms; Cohort Studies; | 2013 |
Low-dose aspirin use and cancer characteristics: a population-based cohort study.
Topics: Adenocarcinoma; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Breast Neoplasms; Cohort Studies; | 2013 |
Low-dose aspirin and survival in men with prostate cancer: a study using the UK Clinical Practice Research Datalink.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Hum | 2014 |
Low-dose aspirin and survival in men with prostate cancer: a study using the UK Clinical Practice Research Datalink.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Hum | 2014 |
A cohort study investigating aspirin use and survival in men with prostate cancer.
Topics: Aged; Aspirin; Cohort Studies; Combined Modality Therapy; Cyclooxygenase Inhibitors; Humans; Male; M | 2014 |
A cohort study investigating aspirin use and survival in men with prostate cancer.
Topics: Aged; Aspirin; Cohort Studies; Combined Modality Therapy; Cyclooxygenase Inhibitors; Humans; Male; M | 2014 |
Aspirin and prostate cancer prevention.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Male; Prostatic Neoplasms; Risk Assessment | 2014 |
Aspirin and prostate cancer prevention.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Male; Prostatic Neoplasms; Risk Assessment | 2014 |
Aspirin improves outcome in high risk prostate cancer patients treated with radiation therapy.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Chemoradiotherapy; Clopidogrel; Drug Screening Ass | 2014 |
Aspirin improves outcome in high risk prostate cancer patients treated with radiation therapy.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Chemoradiotherapy; Clopidogrel; Drug Screening Ass | 2014 |
Perioperative aspirin: to give or not to give?
Topics: Aspirin; Blood Transfusion; Coronary Artery Bypass; Coronary Disease; Female; Fibrinolytic Agents; H | 2014 |
Perioperative aspirin: to give or not to give?
Topics: Aspirin; Blood Transfusion; Coronary Artery Bypass; Coronary Disease; Female; Fibrinolytic Agents; H | 2014 |
Daily aspirin use and prostate cancer-specific mortality in a large cohort of men with nonmetastatic prostate cancer.
Topics: Aged; Aged, 80 and over; Aspirin; Cohort Studies; Humans; Male; Middle Aged; Prospective Studies; Pr | 2014 |
Daily aspirin use and prostate cancer-specific mortality in a large cohort of men with nonmetastatic prostate cancer.
Topics: Aged; Aged, 80 and over; Aspirin; Cohort Studies; Humans; Male; Middle Aged; Prospective Studies; Pr | 2014 |
The impact of the use of aspirin and other nonsteroidal anti-inflammatory drugs on the risk of prostate cancer detection on biopsy.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biopsy; Databases, Factual; Humans; Male; Mi | 2014 |
The impact of the use of aspirin and other nonsteroidal anti-inflammatory drugs on the risk of prostate cancer detection on biopsy.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biopsy; Databases, Factual; Humans; Male; Mi | 2014 |
Editorial comment.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Male; Prostatic Neoplasms | 2014 |
Editorial comment.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Male; Prostatic Neoplasms | 2014 |
Reply: To PMID 25443907.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Male; Prostatic Neoplasms | 2014 |
Reply: To PMID 25443907.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Male; Prostatic Neoplasms | 2014 |
The use of aspirin and the risk of mortality in patients with prostate cancer.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cause of Death; Humans; Male; Prostatic Neop | 2015 |
The use of aspirin and the risk of mortality in patients with prostate cancer.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cause of Death; Humans; Male; Prostatic Neop | 2015 |
Assessment of risk of late rectal bleeding for patients with prostate cancer started on anticoagulation before or after radiation treatment.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Gastrointestinal Hemorrhage; Humans; | 2014 |
Assessment of risk of late rectal bleeding for patients with prostate cancer started on anticoagulation before or after radiation treatment.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Gastrointestinal Hemorrhage; Humans; | 2014 |
More evidence that aspirin lowers cancer risk.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Male; Platelet Aggregation Inhibitors; Pro | 2015 |
More evidence that aspirin lowers cancer risk.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Male; Platelet Aggregation Inhibitors; Pro | 2015 |
Daily aspirin may reduce mortality from prostate cancer with risk of high recurrence.
Topics: Aspirin; Humans; Male; Prostatic Neoplasms | 2015 |
Daily aspirin may reduce mortality from prostate cancer with risk of high recurrence.
Topics: Aspirin; Humans; Male; Prostatic Neoplasms | 2015 |
Simultaneous treatment with statins and aspirin reduces the risk of prostate cancer detection and tumorigenic properties in prostate cancer cell lines.
Topics: Aged; Aspirin; Biopsy; Case-Control Studies; Cell Line, Tumor; Cell Movement; Cell Proliferation; Hu | 2015 |
Simultaneous treatment with statins and aspirin reduces the risk of prostate cancer detection and tumorigenic properties in prostate cancer cell lines.
Topics: Aged; Aspirin; Biopsy; Case-Control Studies; Cell Line, Tumor; Cell Movement; Cell Proliferation; Hu | 2015 |
The risk of prostate cancer for men on aspirin, statin or antidiabetic medications.
Topics: Aspirin; Cohort Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents | 2015 |
The risk of prostate cancer for men on aspirin, statin or antidiabetic medications.
Topics: Aspirin; Cohort Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents | 2015 |
Problematic Use of Multiple Subgroup Analyses in Assessing the Impact of Aspirin in Prostate Cancer.
Topics: Aspirin; Humans; Male; Prostatic Neoplasms | 2015 |
Problematic Use of Multiple Subgroup Analyses in Assessing the Impact of Aspirin in Prostate Cancer.
Topics: Aspirin; Humans; Male; Prostatic Neoplasms | 2015 |
Reply to M. Lee et al.
Topics: Aspirin; Humans; Male; Prostatic Neoplasms | 2015 |
Reply to M. Lee et al.
Topics: Aspirin; Humans; Male; Prostatic Neoplasms | 2015 |
Aspirin and prostate cancer prevention.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Male; Prostatic Neoplasms; Random | 2015 |
Aspirin and prostate cancer prevention.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Male; Prostatic Neoplasms; Random | 2015 |
Use of non-steroidal anti-inflammatory drugs and prostate cancer survival in the Finnish prostate cancer screening trial.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Early Detection of Cancer; Humans; Male; Mid | 2015 |
Use of non-steroidal anti-inflammatory drugs and prostate cancer survival in the Finnish prostate cancer screening trial.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Early Detection of Cancer; Humans; Male; Mid | 2015 |
Preventive Effects of Aspirin on Cardiovascular Complications in Prostate Cancer Cases after Endocrinotherapy.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Car | 2015 |
Preventive Effects of Aspirin on Cardiovascular Complications in Prostate Cancer Cases after Endocrinotherapy.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Car | 2015 |
Formalin therapy for hemorrhagic radiation proctitis.
Topics: Administration, Rectal; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Argon; Asp | 2015 |
Formalin therapy for hemorrhagic radiation proctitis.
Topics: Administration, Rectal; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Argon; Asp | 2015 |
Aspirin and NSAID use in association with molecular subtypes of prostate cancer defined by TMPRSS2:ERG fusion status.
Topics: Adult; Aged; Androgens; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; In Situ Hybridizat | 2016 |
Aspirin and NSAID use in association with molecular subtypes of prostate cancer defined by TMPRSS2:ERG fusion status.
Topics: Adult; Aged; Androgens; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; In Situ Hybridizat | 2016 |
Risk of prostate cancer in low-dose aspirin users: A retrospective cohort study.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Cardiovascular Diseases; Cerebr | 2016 |
Risk of prostate cancer in low-dose aspirin users: A retrospective cohort study.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Cardiovascular Diseases; Cerebr | 2016 |
Postscreening follow-up of the Finnish Prostate Cancer Screening Trial on putative prostate cancer risk factors: vitamin and mineral use, male pattern baldness, pubertal development and non-steroidal anti-inflammatory drug use.
Topics: Aged; Alopecia; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dietary Supplements; Early Detecti | 2016 |
Postscreening follow-up of the Finnish Prostate Cancer Screening Trial on putative prostate cancer risk factors: vitamin and mineral use, male pattern baldness, pubertal development and non-steroidal anti-inflammatory drug use.
Topics: Aged; Alopecia; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dietary Supplements; Early Detecti | 2016 |
The association between regular use of aspirin and the prevalence of prostate cancer: Results from the National Health Interview Survey.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Cross-Sectional St | 2016 |
The association between regular use of aspirin and the prevalence of prostate cancer: Results from the National Health Interview Survey.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Cross-Sectional St | 2016 |
Low-dose aspirin or other nonsteroidal anti-inflammatory drug use and prostate cancer risk: a nationwide study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studi | 2016 |
Low-dose aspirin or other nonsteroidal anti-inflammatory drug use and prostate cancer risk: a nationwide study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studi | 2016 |
Aspirin unmasking acquired haemophilia A in a patient with prostate cancer.
Topics: Aged; Aspirin; Contusions; Hematoma; Hemophilia A; Humans; Male; Partial Thromboplastin Time; Platel | 2016 |
Aspirin unmasking acquired haemophilia A in a patient with prostate cancer.
Topics: Aged; Aspirin; Contusions; Hematoma; Hemophilia A; Humans; Male; Partial Thromboplastin Time; Platel | 2016 |
Combined effects of atorvastatin and aspirin on growth and apoptosis in human prostate cancer cells.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Apoptosis; Aspirin; Ator | 2017 |
Combined effects of atorvastatin and aspirin on growth and apoptosis in human prostate cancer cells.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Apoptosis; Aspirin; Ator | 2017 |
Aspirin Inhibits IKK-β-mediated Prostate Cancer Cell Invasion by Targeting Matrix Metalloproteinase-9 and Urokinase-Type Plasminogen Activator.
Topics: Aspirin; Cell Line, Tumor; Humans; I-kappa B Kinase; Male; Matrix Metalloproteinase 9; Neoplasm Inva | 2017 |
Aspirin Inhibits IKK-β-mediated Prostate Cancer Cell Invasion by Targeting Matrix Metalloproteinase-9 and Urokinase-Type Plasminogen Activator.
Topics: Aspirin; Cell Line, Tumor; Humans; I-kappa B Kinase; Male; Matrix Metalloproteinase 9; Neoplasm Inva | 2017 |
The use of aspirin with PC-SPES may not prevent pulmonary embolism.
Topics: Aged; Anticoagulants; Aspirin; Drugs, Chinese Herbal; Humans; Kallikreins; Male; Prostate-Specific A | 2003 |
The use of aspirin with PC-SPES may not prevent pulmonary embolism.
Topics: Aged; Anticoagulants; Aspirin; Drugs, Chinese Herbal; Humans; Kallikreins; Male; Prostate-Specific A | 2003 |
Nutritional prevention of cancer: new directions for an increasingly complex challenge.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clinical Trials as Topic; Cohort Studies; Cooperat | 2009 |
Nutritional prevention of cancer: new directions for an increasingly complex challenge.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clinical Trials as Topic; Cohort Studies; Cooperat | 2009 |
Association of nonsteroidal anti-inflammatory drugs, prostate specific antigen and prostate volume.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biops | 2009 |
Association of nonsteroidal anti-inflammatory drugs, prostate specific antigen and prostate volume.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biops | 2009 |
Effects of simvastatin, acetylsalicylic acid, and rosiglitazone on proliferation of normal and cancerous prostate epithelial cells at therapeutic concentrations.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cell Division; Cell Line, Transformed; Cell Line, | 2009 |
Effects of simvastatin, acetylsalicylic acid, and rosiglitazone on proliferation of normal and cancerous prostate epithelial cells at therapeutic concentrations.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cell Division; Cell Line, Transformed; Cell Line, | 2009 |
Statins, aspirin affect prostate cancer test.
Topics: Anticholesteremic Agents; Aspirin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pla | 2009 |
Statins, aspirin affect prostate cancer test.
Topics: Anticholesteremic Agents; Aspirin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pla | 2009 |
Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin; Black or Afr | 2010 |
Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin; Black or Afr | 2010 |
Long-term aspirin use and the risk of total, high-grade, regionally advanced and lethal prostate cancer in a prospective cohort of health professionals, 1988-2006.
Topics: Adult; Aged; Anticarcinogenic Agents; Aspirin; Health Personnel; Humans; Male; Middle Aged; Prospect | 2011 |
Long-term aspirin use and the risk of total, high-grade, regionally advanced and lethal prostate cancer in a prospective cohort of health professionals, 1988-2006.
Topics: Adult; Aged; Anticarcinogenic Agents; Aspirin; Health Personnel; Humans; Male; Middle Aged; Prospect | 2011 |
Use of non-steroidal anti-inflammatory drugs and prostate cancer risk: a population-based nested case-control study.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Dose-Response R | 2011 |
Use of non-steroidal anti-inflammatory drugs and prostate cancer risk: a population-based nested case-control study.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Dose-Response R | 2011 |
Differences in characteristics of men with localised prostate cancer who demonstrate low, intermediate or high prostate-specific antigen velocity.
Topics: Adult; Aged; Aspirin; Biomarkers, Tumor; Disease Progression; Follow-Up Studies; Humans; Kallikreins | 2012 |
Differences in characteristics of men with localised prostate cancer who demonstrate low, intermediate or high prostate-specific antigen velocity.
Topics: Adult; Aged; Aspirin; Biomarkers, Tumor; Disease Progression; Follow-Up Studies; Humans; Kallikreins | 2012 |
Chemoprevention: First line of defence.
Topics: Animals; Aspirin; Celecoxib; Clinical Trials, Phase II as Topic; Colonic Neoplasms; Cyclooxygenase I | 2011 |
Chemoprevention: First line of defence.
Topics: Animals; Aspirin; Celecoxib; Clinical Trials, Phase II as Topic; Colonic Neoplasms; Cyclooxygenase I | 2011 |
A retrospective study to assess the morbidity associated with transurethral prostatectomy in patients on antiplatelet or anticoagulant drugs.
Topics: Aged; Anticoagulants; Aspirin; Blood Loss, Surgical; Cardiovascular Diseases; Case-Control Studies; | 2011 |
A retrospective study to assess the morbidity associated with transurethral prostatectomy in patients on antiplatelet or anticoagulant drugs.
Topics: Aged; Anticoagulants; Aspirin; Blood Loss, Surgical; Cardiovascular Diseases; Case-Control Studies; | 2011 |
Aspirin and statin nonuse associated with early biochemical failure after prostate radiation therapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anticoagulants; Antineoplastic | 2012 |
Aspirin and statin nonuse associated with early biochemical failure after prostate radiation therapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anticoagulants; Antineoplastic | 2012 |
Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO study.
Topics: Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Ibuprofen; Male; Middle | 2012 |
Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO study.
Topics: Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Ibuprofen; Male; Middle | 2012 |
Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Chemoprevention; Clopidogre | 2012 |
Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Chemoprevention; Clopidogre | 2012 |
Should warfarin or aspirin be stopped prior to prostate biopsy? An analysis of bleeding complications related to increasing sample number regimes.
Topics: Aged; Anticoagulants; Aspirin; Biopsy; Hemorrhage; Humans; Male; Prospective Studies; Prostatic Neop | 2012 |
Should warfarin or aspirin be stopped prior to prostate biopsy? An analysis of bleeding complications related to increasing sample number regimes.
Topics: Aged; Anticoagulants; Aspirin; Biopsy; Hemorrhage; Humans; Male; Prospective Studies; Prostatic Neop | 2012 |
Aspirin use after a prostate cancer diagnosis and cancer survival in a prospective cohort.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; California; Follow-Up Studies; Humans | 2012 |
Aspirin use after a prostate cancer diagnosis and cancer survival in a prospective cohort.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; California; Follow-Up Studies; Humans | 2012 |
Urological cancer: Aspirin and the risk of prostate cancer mortality.
Topics: Anticoagulants; Aspirin; Humans; Male; Prostatic Neoplasms; Randomized Controlled Trials as Topic; R | 2012 |
Urological cancer: Aspirin and the risk of prostate cancer mortality.
Topics: Anticoagulants; Aspirin; Humans; Male; Prostatic Neoplasms; Randomized Controlled Trials as Topic; R | 2012 |
Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studi | 2013 |
Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studi | 2013 |
Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease.
Topics: Adrenergic beta-Antagonists; Aged; Aspirin; Cohort Studies; Humans; Hydroxymethylglutaryl-CoA Reduct | 2014 |
Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease.
Topics: Adrenergic beta-Antagonists; Aged; Aspirin; Cohort Studies; Humans; Hydroxymethylglutaryl-CoA Reduct | 2014 |
Daily aspirin may thwart prostate cancer.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Male; Middle Aged; Prostatic Neoplas | 2002 |
Daily aspirin may thwart prostate cancer.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Male; Middle Aged; Prostatic Neoplas | 2002 |
Daily aspirin use and prostate cancer risk in a large, multiracial cohort in the US.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cohort Studies; Humans; M | 2002 |
Daily aspirin use and prostate cancer risk in a large, multiracial cohort in the US.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cohort Studies; Humans; M | 2002 |
Superior effectiveness of ibuprofen compared with other NSAIDs for reducing the survival of human prostate cancer cells.
Topics: Acetaminophen; Adenocarcinoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cell Divis | 2002 |
Superior effectiveness of ibuprofen compared with other NSAIDs for reducing the survival of human prostate cancer cells.
Topics: Acetaminophen; Adenocarcinoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cell Divis | 2002 |
Aspirin use in relation to risk of prostate cancer.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cohort Studies; Dose-Response Relatio | 2002 |
Aspirin use in relation to risk of prostate cancer.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cohort Studies; Dose-Response Relatio | 2002 |
Effect of nonsteroidal anti-inflammatory agents and finasteride on prostate cancer risk.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biopsy; Case-Control Studies; Finasteride; H | 2002 |
Effect of nonsteroidal anti-inflammatory agents and finasteride on prostate cancer risk.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biopsy; Case-Control Studies; Finasteride; H | 2002 |
On call. I've read that aspirin may help prevent colon cancer as well as heart attacks. I take an aspirin every day, and I wonder if it may also help with prostate cancer.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin; Colonic Neoplasms; Humans | 2002 |
On call. I've read that aspirin may help prevent colon cancer as well as heart attacks. I take an aspirin every day, and I wonder if it may also help with prostate cancer.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin; Colonic Neoplasms; Humans | 2002 |
What's hot in the prostate?
Topics: Aspirin; Biomarkers, Tumor; Humans; Male; Prostatic Hyperplasia; Prostatic Neoplasms | 2002 |
What's hot in the prostate?
Topics: Aspirin; Biomarkers, Tumor; Humans; Male; Prostatic Hyperplasia; Prostatic Neoplasms | 2002 |
The use of complementary/preventive medicine to prevent prostate cancer recurrence/progression following definitive therapy. Part II--rapid review of dietary supplements.
Topics: Aspirin; Dietary Supplements; Disease Progression; Humans; Male; Prostatic Neoplasms; Selenium; Vita | 2003 |
The use of complementary/preventive medicine to prevent prostate cancer recurrence/progression following definitive therapy. Part II--rapid review of dietary supplements.
Topics: Aspirin; Dietary Supplements; Disease Progression; Humans; Male; Prostatic Neoplasms; Selenium; Vita | 2003 |
Effect of castration on acetyl salicylic acid metabolism in rabbits.
Topics: Androgen Antagonists; Animals; Aspirin; Biotransformation; Castration; Chromatography, High Pressure | 2003 |
Effect of castration on acetyl salicylic acid metabolism in rabbits.
Topics: Androgen Antagonists; Animals; Aspirin; Biotransformation; Castration; Chromatography, High Pressure | 2003 |
Morbidity of transrectal ultrasonography-guided prostate biopsies in patients after the continued use of low-dose aspirin.
Topics: Aspirin; Biopsy, Needle; Blood; Cohort Studies; Gastrointestinal Hemorrhage; Hematuria; Hemorrhage; | 2003 |
Morbidity of transrectal ultrasonography-guided prostate biopsies in patients after the continued use of low-dose aspirin.
Topics: Aspirin; Biopsy, Needle; Blood; Cohort Studies; Gastrointestinal Hemorrhage; Hematuria; Hemorrhage; | 2003 |
Delayed life-threatening hemorrhage after transrectal prostate needle biopsy.
Topics: Aspirin; Biopsy, Needle; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregatio | 2003 |
Delayed life-threatening hemorrhage after transrectal prostate needle biopsy.
Topics: Aspirin; Biopsy, Needle; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregatio | 2003 |
Aspirin inhibits highly invasive prostate cancer cells.
Topics: Actins; Aspirin; Cell Adhesion; Cell Line, Tumor; Cell Movement; Chloramphenicol O-Acetyltransferase | 2003 |
Aspirin inhibits highly invasive prostate cancer cells.
Topics: Actins; Aspirin; Cell Adhesion; Cell Line, Tumor; Cell Movement; Chloramphenicol O-Acetyltransferase | 2003 |
P-glycoprotein increases the efflux of the androgen dihydrotestosterone and reduces androgen responsive gene activity in prostate tumor cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; ATP Binding Cassette Transporter, Subfamily B, Mem | 2004 |
P-glycoprotein increases the efflux of the androgen dihydrotestosterone and reduces androgen responsive gene activity in prostate tumor cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; ATP Binding Cassette Transporter, Subfamily B, Mem | 2004 |
Inverse association between nonsteroidal anti-inflammatory drugs and prostate cancer.
Topics: Acetaminophen; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Cohort | 2004 |
Inverse association between nonsteroidal anti-inflammatory drugs and prostate cancer.
Topics: Acetaminophen; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Cohort | 2004 |
Nitric oxide donating nonsteroidal anti-inflammatory drugs induce apoptosis in human prostate cancer cell systems and human prostatic stroma via caspase-3.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Caspase 3; Caspases; Cell Division; Col | 2004 |
Nitric oxide donating nonsteroidal anti-inflammatory drugs induce apoptosis in human prostate cancer cell systems and human prostatic stroma via caspase-3.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Caspase 3; Caspases; Cell Division; Col | 2004 |
Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging.
Topics: Acetaminophen; Aged; Aging; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Aspir | 2005 |
Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging.
Topics: Acetaminophen; Aged; Aging; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Aspir | 2005 |
Biopsy of the prostate guided by transrectal ultrasound: relation between warfarin use and incidence of bleeding complications.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Biopsy; Blood; Fibrinolytic Agents; Follow-Up Stud | 2005 |
Biopsy of the prostate guided by transrectal ultrasound: relation between warfarin use and incidence of bleeding complications.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Biopsy; Blood; Fibrinolytic Agents; Follow-Up Stud | 2005 |
Anti-inflammatory drugs and malignancy: can an aspirin a day keep cancer at bay?
Topics: Aspirin; Breast Neoplasms; Colorectal Neoplasms; Cyclooxygenase Inhibitors; Female; Humans; Male; Ne | 2005 |
Anti-inflammatory drugs and malignancy: can an aspirin a day keep cancer at bay?
Topics: Aspirin; Breast Neoplasms; Colorectal Neoplasms; Cyclooxygenase Inhibitors; Female; Humans; Male; Ne | 2005 |
Clinical trials point to complexities of chemoprevention for cancer.
Topics: Aspirin; Breast Neoplasms; Clinical Trials as Topic; Diet; Dihydrotestosterone; Female; Finasteride; | 2005 |
Clinical trials point to complexities of chemoprevention for cancer.
Topics: Aspirin; Breast Neoplasms; Clinical Trials as Topic; Diet; Dihydrotestosterone; Female; Finasteride; | 2005 |
A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cohort Studies; Confidenc | 2005 |
A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cohort Studies; Confidenc | 2005 |
Pretreatment of acetylsalicylic acid promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by down-regulating BCL-2 gene expression.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Aspirin; Blotting, Western; Caspase 3; Caspase 8; Caspase | 2005 |
Pretreatment of acetylsalicylic acid promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by down-regulating BCL-2 gene expression.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Aspirin; Blotting, Western; Caspase 3; Caspase 8; Caspase | 2005 |
Aspirin and the risk of prostate cancer.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Cyclooxygenase Inhibit | 2006 |
Aspirin and the risk of prostate cancer.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Cyclooxygenase Inhibit | 2006 |
Regular use of aspirin and prostate cancer risk (United States).
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Confidence Intervals; | 2006 |
Regular use of aspirin and prostate cancer risk (United States).
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Confidence Intervals; | 2006 |
Non-steroidal anti-inflammatory drug use and prostate cancer in a high-risk population.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Canada; Chemoprevention; Cross-Sectional Stu | 2006 |
Non-steroidal anti-inflammatory drug use and prostate cancer in a high-risk population.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Canada; Chemoprevention; Cross-Sectional Stu | 2006 |
Aspirin use and transrectal ultrasonography-guided prostate biopsy: a national survey.
Topics: Aspirin; Biopsy, Needle; Blood Loss, Surgical; Health Surveys; Humans; Male; Platelet Aggregation In | 2007 |
Aspirin use and transrectal ultrasonography-guided prostate biopsy: a national survey.
Topics: Aspirin; Biopsy, Needle; Blood Loss, Surgical; Health Surveys; Humans; Male; Platelet Aggregation In | 2007 |
Plasma antibodies against Chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: a prospective study.
Topics: Adult; Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Bacterial; Antibodies | 2007 |
Plasma antibodies against Chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: a prospective study.
Topics: Adult; Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Bacterial; Antibodies | 2007 |
Aspirin enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation.
Topics: Apoptosis; Aspirin; Cell Line, Tumor; Down-Regulation; Humans; Inhibitor of Apoptosis Proteins; Male | 2007 |
Aspirin enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation.
Topics: Apoptosis; Aspirin; Cell Line, Tumor; Down-Regulation; Humans; Inhibitor of Apoptosis Proteins; Male | 2007 |
Aspirin and hormone therapy for prostate cancer.
Topics: Androgen Antagonists; Aspirin; Atorvastatin; Drug Therapy, Combination; Flutamide; Gonadotropin-Rele | 2007 |
Aspirin and hormone therapy for prostate cancer.
Topics: Androgen Antagonists; Aspirin; Atorvastatin; Drug Therapy, Combination; Flutamide; Gonadotropin-Rele | 2007 |
Trouble at dinner: an unusual case of eating-induced seizures.
Topics: Aged; Anticonvulsants; Aspirin; Brain Stem Neoplasms; Carbamazepine; Drug Administration Schedule; D | 2008 |
Trouble at dinner: an unusual case of eating-induced seizures.
Topics: Aged; Anticonvulsants; Aspirin; Brain Stem Neoplasms; Carbamazepine; Drug Administration Schedule; D | 2008 |
Role of surface negative charge in platelet function related to the hyperreactive state in estrogen-treated prostatic carcinoma.
Topics: Aged; Aspirin; Blood Platelets; Cell Membrane; Cell Movement; Diethylstilbestrol; Dose-Response Rela | 1982 |
Role of surface negative charge in platelet function related to the hyperreactive state in estrogen-treated prostatic carcinoma.
Topics: Aged; Aspirin; Blood Platelets; Cell Membrane; Cell Movement; Diethylstilbestrol; Dose-Response Rela | 1982 |
Binding of estradiol to whole prostatic DU-145 cells in the presence and absence of tamoxifen and acetylsalicylic acid.
Topics: Aspirin; Binding, Competitive; Cytoplasm; Diethylstilbestrol; Dihydrotestosterone; Estradiol; Estrog | 1995 |
Binding of estradiol to whole prostatic DU-145 cells in the presence and absence of tamoxifen and acetylsalicylic acid.
Topics: Aspirin; Binding, Competitive; Cytoplasm; Diethylstilbestrol; Dihydrotestosterone; Estradiol; Estrog | 1995 |
[Changes in parameters of the coagulation and fibrinolysis system of the blood in patients with prostate cancer in the framework of estrogen therapy].
Topics: Aged; Antihypertensive Agents; Aspirin; Blood Coagulation Disorders; Blood Coagulation Tests; Cardio | 1994 |
[Changes in parameters of the coagulation and fibrinolysis system of the blood in patients with prostate cancer in the framework of estrogen therapy].
Topics: Aged; Antihypertensive Agents; Aspirin; Blood Coagulation Disorders; Blood Coagulation Tests; Cardio | 1994 |
Re: Advances in angiogenesis research: relevance to urological oncology.
Topics: Aspirin; Humans; Male; Neovascularization, Pathologic; Prostatic Neoplasms; Research | 1998 |
Re: Advances in angiogenesis research: relevance to urological oncology.
Topics: Aspirin; Humans; Male; Neovascularization, Pathologic; Prostatic Neoplasms; Research | 1998 |
Non-steroidal anti-inflammatory drugs and prostate cancer progression.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Aspir | 1998 |
Non-steroidal anti-inflammatory drugs and prostate cancer progression.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Aspir | 1998 |
Association between coronary heart disease and cancers of the breast, prostate, and colon.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Breast Neoplasms; Case-Control Studies; Colo | 1998 |
Association between coronary heart disease and cancers of the breast, prostate, and colon.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Breast Neoplasms; Case-Control Studies; Colo | 1998 |
Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
Topics: Adult; Aged; Aged, 80 and over; Antioxidants; Aspirin; beta Carotene; Carotenoids; Case-Control Stud | 1999 |
Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
Topics: Adult; Aged; Aged, 80 and over; Antioxidants; Aspirin; beta Carotene; Carotenoids; Case-Control Stud | 1999 |
Transrectal ultrasound-guided biopsy of the prostate: relation between ASA use and bleeding complications.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Biopsy, Needle; Endosonography; Humans; Male; Middle Aged; | 1999 |
Transrectal ultrasound-guided biopsy of the prostate: relation between ASA use and bleeding complications.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Biopsy, Needle; Endosonography; Humans; Male; Middle Aged; | 1999 |
Contrasting effects of aspirin on prostate cancer cells: suppression of proliferation and induction of drug resistance .
Topics: Antineoplastic Agents; Aspirin; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Divisi | 2000 |
Contrasting effects of aspirin on prostate cancer cells: suppression of proliferation and induction of drug resistance .
Topics: Antineoplastic Agents; Aspirin; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Divisi | 2000 |
Stilboestrol plus adrenal suppression as salvage treatment for patients failing treatment with luteinizing hormone-releasing hormone analogues and orchidectomy.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Aspirin; Diethylstilbestrol; Drug Therapy, | 2000 |
Stilboestrol plus adrenal suppression as salvage treatment for patients failing treatment with luteinizing hormone-releasing hormone analogues and orchidectomy.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Aspirin; Diethylstilbestrol; Drug Therapy, | 2000 |
Protein kinase C epsilon mediates the induction of P-glycoprotein in LNCaP prostate carcinoma cells.
Topics: Aspirin; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma; Diterpenes; Enzyme Inhi | 2002 |
Protein kinase C epsilon mediates the induction of P-glycoprotein in LNCaP prostate carcinoma cells.
Topics: Aspirin; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma; Diterpenes; Enzyme Inhi | 2002 |
NSAIDs and a lower risk of prostate cancer: causation or confounding?
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Causality; Confounding Factors, Epidemiologi | 2002 |
NSAIDs and a lower risk of prostate cancer: causation or confounding?
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Causality; Confounding Factors, Epidemiologi | 2002 |
Investigations on prostatic adenocarcinomas in rats.
Topics: Adenocarcinoma; Anesthetics; Animals; Aspirin; Cell Line; Female; Immunotherapy; Indomethacin; Lung | 1977 |
Investigations on prostatic adenocarcinomas in rats.
Topics: Adenocarcinoma; Anesthetics; Animals; Aspirin; Cell Line; Female; Immunotherapy; Indomethacin; Lung | 1977 |
Inhibition of platelet aggregation caused by estrogen treatment in patients with carcinoma of the prostate.
Topics: Aspirin; Castration; Diethylstilbestrol; Estradiol; Estrogens; Humans; Male; Platelet Adhesiveness; | 1975 |
Inhibition of platelet aggregation caused by estrogen treatment in patients with carcinoma of the prostate.
Topics: Aspirin; Castration; Diethylstilbestrol; Estradiol; Estrogens; Humans; Male; Platelet Adhesiveness; | 1975 |
[Inhibition of platelet aggregation under estrogen-treatment in patients with carcinoma of the prostate (author's transl)].
Topics: Aspirin; Blood Coagulation Disorders; Blood Platelets; Diethylstilbestrol; Estrogens; Humans; Male; | 1975 |
[Inhibition of platelet aggregation under estrogen-treatment in patients with carcinoma of the prostate (author's transl)].
Topics: Aspirin; Blood Coagulation Disorders; Blood Platelets; Diethylstilbestrol; Estrogens; Humans; Male; | 1975 |
Dilemmas in managing prostate carcinoma (Part II): Metastatic disease.
Topics: Aged; Aminoglutethimide; Aspirin; Bone Neoplasms; Castration; Diethylstilbestrol; Disseminated Intra | 1985 |
Dilemmas in managing prostate carcinoma (Part II): Metastatic disease.
Topics: Aged; Aminoglutethimide; Aspirin; Bone Neoplasms; Castration; Diethylstilbestrol; Disseminated Intra | 1985 |